<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Prostate Cancer on VitaminDWiki</title><link>/categories/prostate-cancer.html</link><description>Recent content in Prostate Cancer on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sun, 24 Mar 2024 00:00:00 +0000</lastBuildDate><atom:link href="/categories/prostate-cancer/index.xml" rel="self" type="application/rss+xml"/><item><title>50,000 IU of Vitamin D weekly greatly decreased bone loss from prostate cancer therapy - RCT</title><link>/posts/50000-iu-of-vitamin-d-weekly-greatly-decreased-bone-loss-from-prostate-cancer-therapy-rct.html</link><pubDate>Sun, 24 Mar 2024 00:00:00 +0000</pubDate><guid>/posts/50000-iu-of-vitamin-d-weekly-greatly-decreased-bone-loss-from-prostate-cancer-therapy-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#high-dose-vitamin-d-to-attenuate-bone-loss-in-patients-with-prostate-cancer-on-androgen-deprivation-therapy-a-phase-2-rct">High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="high-dose-vitamin-d-to-attenuate-bone-loss-in-patients-with-prostate-cancer-on-androgen-deprivation-therapy-a-phase-2-rct">High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT&lt;/h4>
&lt;p>Cancer . 2024 Mar 23. &lt;a href="https://doi.org/10.1002/cncr.35275">doi: 10.1002/cncr.35275&lt;/a> PDF is behind a paywall&lt;/p>
&lt;p>Luke J Peppone 1 2, Amber S Kleckner 3, Chunkit Fung 4, J Edward Puzas 2, Jennifer E Reschke 1, Eva Culakova 1, Julia Inglis 5, Charles Kamen 1, Jonathan W Friedberg 4, Michelle Janelsins 1, Karen Mustian 1, Charles E Heckler 1, Supriya Mohile 4&lt;/p></description></item><item><title>Two types of Prostate Cancer – one is far more lethal</title><link>/posts/two-types-of-prostate-cancer-one-is-far-more-lethal.html</link><pubDate>Thu, 14 Mar 2024 00:00:00 +0000</pubDate><guid>/posts/two-types-of-prostate-cancer-one-is-far-more-lethal.html</guid><description>&lt;p>&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/2nd-pc-low-survival.png" alt="image" width="350"> &lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/pc-gleason.png" alt="image" width="350">&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#genomic-evolution-shapes-prostate-cancer-disease-type">Genomic evolution shapes prostate cancer disease type&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="genomic-evolution-shapes-prostate-cancer-disease-type">Genomic evolution shapes prostate cancer disease type&lt;/h4>
&lt;p>Cell Geonomics VOL 4, # 3, 100511, MARCH 13, 2024 &lt;a href="https://doi.org/10.1016/j.xgen.2024.100511">https://doi.org/10.1016/j.xgen.2024.100511&lt;/a>&lt;/p>
&lt;p>Dan J. Woodcock, Atef Sahli, Ruxandra Teslo, Rosalind A. Eeles 43, Colin S. Cooper 43, David C. Wedge 43, 46&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Analysis of genomic data from localized prostate cancer reveals divergent evolution&lt;/p>
&lt;/li>
&lt;li>
&lt;p>The shift away from the canonical trajectory is characterized by AR dysregulation&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Tumors can be classified into evotypes according to evolutionary trajectory&lt;/p></description></item><item><title>1.5X more likely to die of Prostate Cancer if low vitamin D when initially diagnosed – meta-analysis</title><link>/posts/15x-more-likely-to-die-of-prostate-cancer-if-low-vitamin-d-when-initially-diagnosed-meta-analysis.html</link><pubDate>Wed, 13 Mar 2024 00:00:00 +0000</pubDate><guid>/posts/15x-more-likely-to-die-of-prostate-cancer-if-low-vitamin-d-when-initially-diagnosed-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#association-between-pretreatment-blood-25-hydroxyvitamin-d-level-and-survival-outcomes-in-patients-with-clinically-localized-prostate-cancer-an-updated-meta-analysis">Association Between Pretreatment Blood 25-Hydroxyvitamin D Level and Survival Outcomes in Patients With Clinically Localized Prostate Cancer: An Updated Meta-Analysis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="association-between-pretreatment-blood-25-hydroxyvitamin-d-level-and-survival-outcomes-in-patients-with-clinically-localized-prostate-cancer-an-updated-meta-analysis">Association Between Pretreatment Blood 25-Hydroxyvitamin D Level and Survival Outcomes in Patients With Clinically Localized Prostate Cancer: An Updated Meta-Analysis&lt;/h4>
&lt;p>Nutr Cancer. 2024 Mar 13:1-9. &lt;a href="https://doi.org/10.1080/01635581.2024.2328378">doi: 10.1080/01635581.2024.2328378&lt;/a> PDF is behind $53 paywall&lt;/p>
&lt;p>Feilun Cui 1 2, Yue Qiu 3, Wei Xu 3, Chen Zou 4, Yu Fan 3&lt;/p>
&lt;p>Studies on the prognostic value of the blood 25-hydroxyvitamin D level have yielded controversial results in prostate cancer (PCa) patients. This updated meta-analysis aimed to evaluate the association between pretreatment 25-hydroxyvitamin D level with survival outcomes among patients with clinically localized PCa. PubMed, Web of Science, and Embase databases were searched to identify studies evaluating the association of pretreatment 25-hydroxyvitamin D level with PCSM and all-cause mortality among clinically localized PCa patients. Ten cohort studies with 10,394 patients were identified. The meta-analysis revealed that PCa patients with the lowest 25-hydroxyvitamin D levels had an increased risk of PCSM (adjusted hazard ratio &lt;span>[HR]&lt;/span> &lt;strong>1.52&lt;/strong> ; 95% confidence interval &lt;span>[CI]&lt;/span> 1.26-1.83; p &amp;lt; 0.001) and all-cause mortality (adjusted HR 1.31; 95% CI 1.00-1.90; p = 0.047) compared to those with higher reference 25-hydroxyvitamin D level. Subgroup analyses based on different sample sizes, follow-up duration, and adjusted times of blood draw also exhibited a significant association of vitamin D deficiency with the risk of PCSM. Lower pretreatment level of 25-hydroxyvitamin D may be an independent predictor of reduced survival in patients with clinically localized PCa. Measuring the pretreatment blood 25-hydroxyvitamin D level can provide valuable information for risk stratification of survival outcomes in these patients.&lt;/p></description></item><item><title>Prostate Cancer - interview of Dr. Holick by Baggerly - video and transcript</title><link>/posts/prostate-cancer-interview-of-dr-holick-by-baggerly-video-and-transcript.html</link><pubDate>Thu, 18 Jan 2024 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-interview-of-dr-holick-by-baggerly-video-and-transcript.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#diagnosis-prostate-cancer-an-interview-with-dr-michael-holick-and-carole-baggerly">Diagnosis Prostate Cancer: An Interview with Dr. Michael Holick and Carole Baggerly&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#transcript">Transcript&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#his-ongoing-diary-on-facebookhttpswwwfacebookcomsearchtopqholick20prostate20cancer">His ongoing diary on &lt;a href="https://www.facebook.com/search/top?q=holick%20prostate%20cancer">Facebook&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-ha-been-use-to-reduce-hot-flahes-prevent-protate-cancer-etc">Vitamin D ha been use to reduce hot flahes, prevent Protate Cancer, etc.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#psa-rct-problems---2014">PSA RCT problems - 2014&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="diagnosis-prostate-cancer-an-interview-with-dr-michael-holick-and-carole-baggerly">Diagnosis Prostate Cancer: An Interview with Dr. Michael Holick and Carole Baggerly&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.youtube.com/watch?v=BMjmsmtdYnM&amp;amp;ab_channel=vitaminDaction">YouTube 48 minutes&lt;/a>&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/png/hollick-baggerly.png" alt="image" width="400">
&lt;hr>
&lt;h4 id="transcript">Transcript&lt;/h4>
&lt;p>(Actual Start at 0:00:13)&lt;/p>
&lt;p>0:02:33.6 &lt;strong>Carole:&lt;/strong> Welcome to one of our fantastic interviews with Dr Michael Holick. Dr. Holick today is gonna talk with us about prostate cancer and what he&amp;rsquo;s done about it. Obviously, he&amp;rsquo;s got it. So we need to know more about how he has been working with it and any advice he has for those that could benefit. So Dr. Holick, why don&amp;rsquo;t you kick it off.&lt;/p></description></item><item><title>Prostate cancer patients in Jamaica were 5X more likely to die of PC if low vitamin D</title><link>/posts/prostate-cancer-patients-in-jamaica-were-5x-more-likely-to-die-of-pc-if-low-vitamin-d.html</link><pubDate>Sat, 01 Oct 2022 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-patients-in-jamaica-were-5x-more-likely-to-die-of-pc-if-low-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-deficiency-at-diagnosis-increases-all-cause-and-prostate-cancer-specific-mortality-in-jamaican-men">Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-deficiency-at-diagnosis-increases-all-cause-and-prostate-cancer-specific-mortality-in-jamaican-men">Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men&lt;/h4>
&lt;p>022 Jan-Dec;29 &lt;a href="https://doi.org/10.1177/10732748221131225.">doi: 10.1177/10732748221131225.&lt;/a>&lt;/p>
&lt;p>Donovan McGrowder 1, Marshall K Tulloch-Reid 2, Kathleen C M Coard 1, Afette M McCaw-Binns 3, Trevor S Ferguson 2, William Aiken 4, Leroy Harrison 5, Simon G Anderson 6, Maria D Jackson 3&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pc-mortality.jpg" alt="image" width="600">
&lt;p>Background: 25 hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> and serum calcium have been associated with incident prostate cancer (PCa). However, there is limited data on whether these metabolites predict survival in men of African descent, a population disproportionately affected by PCa. We studied the relationship of 25(OH)D at PCa diagnosis with all-cause and cancer-specific mortality among Jamaican men and examined whether serum calcium modified any associations.&lt;/p></description></item><item><title>2.5 X reduced risk of cancer in 70 year-olds by a small amount of Vitamin D, Omega-3 and exercise – RCT</title><link>/posts/25-x-reduced-risk-of-cancer-in-70-year-olds-by-a-small-amount-of-vitamin-d-omega-3-and-exercise-rct.html</link><pubDate>Mon, 25 Apr 2022 00:00:00 +0000</pubDate><guid>/posts/25-x-reduced-risk-of-cancer-in-70-year-olds-by-a-small-amount-of-vitamin-d-omega-3-and-exercise-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#combined-vitamin-d-omega-3-fatty-acids-and-a-simple-home-exercise-program-may-reduce-cancer-risk-among-active-adults-aged-70-and-older-a-randomized-clinical-trial">Combined Vitamin D, Omega-3 Fatty Acids, and a Simple Home Exercise Program May Reduce Cancer Risk Among Active Adults Aged 70 and Older: A Randomized Clinical Trial&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-is-the-3rd-best-way-to-improve-your-health-but-the-most-cost-effective">Vitamin D is the 3rd best way to improve your health (but the most cost-effective)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="combined-vitamin-d-omega-3-fatty-acids-and-a-simple-home-exercise-program-may-reduce-cancer-risk-among-active-adults-aged-70-and-older-a-randomized-clinical-trial">Combined Vitamin D, Omega-3 Fatty Acids, and a Simple Home Exercise Program May Reduce Cancer Risk Among Active Adults Aged 70 and Older: A Randomized Clinical Trial&lt;/h4>
&lt;p>Clinical Trial. Front. Aging 3:852643. &lt;a href="https://doi.org/10.3389/fragi.2022.852643">doi: 10.3389/fragi.2022.852643&lt;/a>&lt;/p></description></item><item><title>Prostate Cancer PSA reduced by 60 ng of Vitamin D, Vitamin B complex, Omega-3, Curcumin and diet</title><link>/posts/prostate-cancer-psa-reduced-by-60-ng-of-vitamin-d-vitamin-b-complex-omega-3-curcumin-and-diet.html</link><pubDate>Sun, 20 Jun 2021 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-psa-reduced-by-60-ng-of-vitamin-d-vitamin-b-complex-omega-3-curcumin-and-diet.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#correlative-analysis-of-vitamin-d-and-omega-3-fatty-acid-intake-in-men-on-active-surveillance-for-prostate-cancer">Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="correlative-analysis-of-vitamin-d-and-omega-3-fatty-acid-intake-in-men-on-active-surveillance-for-prostate-cancer">Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer&lt;/h4>
&lt;p>Urology. 2021 Jun 15;S0090-4295(21)00525-2. &lt;a href="https://doi.org/10.1016/j.urology.2021.04.050">doi: 10.1016/j.urology.2021.04.050&lt;/a>&lt;/p>
&lt;p>Rebecca A Campbell 1, Jianbo Li 2, Lindsay Malone 3, David A Levy 4&lt;/p>
&lt;p>&lt;strong>Chart via Google Images&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/prostate-cancer.jpg" alt="image" width="800">
&lt;p>Objectves: To investigate the influence of targeted serum vitamin-D level and omega-6:3 fatty-acid ratio on prostate-specific antigen (PSA) level in men with prostate cancer managed with active surveillance by providing a nutritional intervention and vitamin supplementation.&lt;/p></description></item><item><title>Book: Sunlight, UV, Vitamin D and Receptor, Skin and other Cancers</title><link>/posts/book-sunlight-uv-vitamin-d-and-receptor-skin-and-other-cancers.html</link><pubDate>Wed, 09 Dec 2020 00:00:00 +0000</pubDate><guid>/posts/book-sunlight-uv-vitamin-d-and-receptor-skin-and-other-cancers.html</guid><description>&lt;h4 id="sunlight-vitamin-d-and-skin-cancer-third-edition---2020">Sunlight, Vitamin D and Skin Cancer Third Edition - 2020&lt;/h4>
&lt;h2 id="i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfreichrath-sci-hubpdfdownload-from-sci-hub-via-vitamindwikia">&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/reichrath-sci-hub.pdf">Download from sci-hub via VitaminDWiki&lt;/a>&lt;/h2>
&lt;p>&lt;strong>Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/toc1.jpg" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/toc2.jpg" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/toc3.jpg" alt="image" width="700"></description></item><item><title>BPH (PSA) decreased by Vitamin D (50,000 IU bi-weekly) – RCT</title><link>/posts/bph-psa-decreased-by-vitamin-d-50000-iu-bi-weekly-rct.html</link><pubDate>Sat, 21 Nov 2020 00:00:00 +0000</pubDate><guid>/posts/bph-psa-decreased-by-vitamin-d-50000-iu-bi-weekly-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-effect-of-vitamin-d-supplementation-on-the-progression-of-benign-prostatic-hyperplasia-a-randomized-controlled-trial">The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-effect-of-vitamin-d-supplementation-on-the-progression-of-benign-prostatic-hyperplasia-a-randomized-controlled-trial">The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial&lt;/h4>
&lt;p>Clin Nutr, . 2020 Nov 7;S0261-5614(20)30609-9. &lt;a href="https://doi.org/10.1016/j.clnu.2020.11.005">doi: 10.1016/j.clnu.2020.11.005&lt;/a>&lt;/p>
&lt;p>Abolfazl Zendehdel 1, Mohsen Ansari 2, Farnaz Khatami 3, Shapour Mansoursamaei 4, Hossein Dialameh 5&lt;/p>
&lt;p>Background and aims: Inflammation and proliferation are the cause of benign prostatic hyperplasia (BPH) and are the key components of its mechanism of action. In this study we sought to determine the role of 25-hydroxyvitamin D in BPH, because of its anti-inflammatory activities, and its effect on prostate volume and BPH symptoms.&lt;/p></description></item><item><title>Deaths from many types of Cancer associated with low vitamin D- review of meta-analyses</title><link>/posts/deaths-from-many-types-of-cancer-associated-with-low-vitamin-d-review-of-meta-analyses.html</link><pubDate>Mon, 09 Nov 2020 00:00:00 +0000</pubDate><guid>/posts/deaths-from-many-types-of-cancer-associated-with-low-vitamin-d-review-of-meta-analyses.html</guid><description/></item><item><title>Breast, Prostate and Colon Cancers are still strongly associated with low Vitamin D – Grant</title><link>/posts/breast-prostate-and-colon-cancers-are-still-strongly-associated-with-low-vitamin-d-grant.html</link><pubDate>Tue, 31 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/breast-prostate-and-colon-cancers-are-still-strongly-associated-with-low-vitamin-d-grant.html</guid><description>&lt;p>&lt;strong>Review of Recent Advances in Understanding the Role of Vitamin D in Reducing Cancer Risk: Breast, Colorectal, Prostate, and Overall Cancer&lt;/strong>&lt;/p>
&lt;p>Anticancer Research 40: 491-499 (2020). &lt;a href="https://doi.org/10.21873/anticanres">doi: 10.21873/anticanres&lt;/a> .13977&lt;/p>
&lt;p>WILLIAM B. GRANT, Sunlight, Nutrition, and Health Research Center, San Francisco, CA, U.S.A.&lt;/p>
&lt;p>Director, Sunlight, Nutrition, and Health Research Center, P.O. Box 641603, San Francisco, CA 94164-1603, USA. &lt;a href="mailto:wbgrant@infionline.net">wbgrant@infionline.net&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>This study is an update of &lt;a href="/posts/evidence-that-vitamin-d-prevents-cancer-grant">Evidence that Vitamin D prevents Cancer – Grant Feb 2018&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Reduce Prostate Cancer Risk: 1.3 X if eat specific plants, 1.7X if add Vitamin D</title><link>/posts/reduce-prostate-cancer-risk-13-x-if-eat-specific-plants-17x-if-add-vitamin-d.html</link><pubDate>Sun, 22 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/reduce-prostate-cancer-risk-13-x-if-eat-specific-plants-17x-if-add-vitamin-d.html</guid><description>&lt;h4 id="plant-bioactives-and-the-prevention-of-prostate-cancer-evidence-from-human-studies--sept-2019">Plant Bioactives and the Prevention of Prostate Cancer: Evidence from Human Studies – Sept 2019&lt;/h4>
&lt;p>Nutrients. 2019 Sep 18;11(9). pii: E2245. &lt;a href="https://doi.org/10.3390/nu11092245.">doi: 10.3390/nu11092245.&lt;/a>&lt;/p>
&lt;p>Livingstone TL1,2, Beasy G3, Mills RD4, Plumb J5, Needs PW6, Mithen R7,8, Traka MH9.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>1.7X reduction if add Vitamin D&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/the-use-of-vitamin-d-to-prevent-prostate-cancer-doubled-in-a-decade">The use of Vitamin D to prevent prostate cancer doubled in a decade – May 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/prostate-cancer-psa-reduced-by-60-ng-of-vitamin-d-vitamin-b-complex-omega-3-curcumin-and-diet">Prostate Cancer PSA reduced by 60 ng of Vitamin D, Vitamin B complex, Omega-3, Curcumin and diet – June 2021&lt;/a>&lt;/p></description></item><item><title>Prostate Cancer associated with various genes, including Vitamin D Receptor and CYP24A1</title><link>/posts/prostate-cancer-associated-with-various-genes-including-vitamin-d-receptor-and-cyp24a1.html</link><pubDate>Fri, 15 Nov 2019 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-associated-with-various-genes-including-vitamin-d-receptor-and-cyp24a1.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#identification-of-novel-markers-of-prostate-cancer-progression-potentially-modulated-by-vitamin-d">Identification of Novel Markers of Prostate Cancer Progression, Potentially Modulated by Vitamin D&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="identification-of-novel-markers-of-prostate-cancer-progression-potentially-modulated-by-vitamin-d">Identification of Novel Markers of Prostate Cancer Progression, Potentially Modulated by Vitamin D&lt;/h4>
&lt;p>Appl. Sci. 2019, 9(22), 4923; &lt;a href="https://doi.org/10.3390/app9224923">https://doi.org/10.3390/app9224923&lt;/a>&lt;/p>
&lt;p>Rosario Caltabiano 1,Paola Castrogiovanni 2OrcID,Ignazio Barbagallo 3,Silvia Ravalli 2OrcID,Marta Anna Szychlinska 2OrcID,Vincenzo Favilla 4,Luigi Schiavo 5OrcID,Rosa Imbesi 2OrcID,Giuseppe Musumeci 2OrcID andMichelino Di Rosa 2,*OrcID&lt;/p>
&lt;p>&lt;strong>Two Vitamin D genes associated with PC&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/prostate-cancer-genes.jpg" alt="image" width="400">
&lt;p>Prostate cancer (PCa) is one of the most common cancers in men. The main risk factors associated with the disease include older age, family history of the disease, smoking, alcohol and race. Vitamin D is a pleiotropic hormone whose low levels are associated with several diseases and a risk of cancer. Here, we undertook microarray analysis in order to identify the genes involved in PCa. We analyzed three PCa microarray datasets, overlapped all genes significantly up-regulated, and subsequently intersected the common genes identified with the down-regulated genes transcriptome of LNCaP cells treated with 1α,25(OH)2D3, in order to identify the common genes involved in PCa and potentially modulated by Vitamin D. The analysis yielded 43 genes potentially involved in PCa and significantly modulated by Vitamin D. Noteworthy, our analysis showed that six genes (PRSS8, SOX4, SMYD2, MCCC2, CCNG2 and CD2AP) were significantly modulated. A Pearson correlation analysis showed that five genes out of six (SOX4 was independent), were statistically correlated with the gene expression levels of KLK3, and with the tumor percentage. From the outcome of our investigation, it is possible to conclude that the genes identified by our analysis are associated with the PCa and are potentially modulated by the Vitamin D&lt;/p></description></item><item><title>Prostate cancer risk cut in half by consuming Boron-rich food or water</title><link>/posts/prostate-cancer-risk-cut-in-half-by-consuming-boron-rich-food-or-water.html</link><pubDate>Tue, 03 Sep 2019 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-risk-cut-in-half-by-consuming-boron-rich-food-or-water.html</guid><description>&lt;h3 id="summary-by-vitamindwiki">Summary by VitaminDWiki&lt;/h3>
&lt;p>&lt;strong>Clearly Boron in food/water reduces risk of Prostate Cancer&lt;br>
Found no data showing that taking Boron will provide the same benefit&lt;br>
Hypothesis that fructo-boron might be a better form&lt;br>
Adding Vitamin D and Omega-3 also decreases the risk of Prostate Cancer&lt;/strong>&lt;/p>
&lt;h4 id="references">References&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Boron and Prostate Cancer a Model for Understanding Boron Biology&lt;/p>
&lt;ul>
&lt;li>2007 &lt;a href="https://doi.org/10.1007/978-1-4020-5382-5_28">https://doi.org/10.1007/978-1-4020-5382-5_28&lt;/a>,&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.newsmax.com/health/health-news/boron-prostate-cancer-treatment-mens-health/2018/09/04/id/880120/">Boron Slashes Risk of Prostate Cancer&lt;/a> Sept 2018&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Dietary boron intake and prostate cancer risk. 2004 DOI: 10.3892/or.11.4.887&lt;/p></description></item><item><title>Men with High Omega-3 ratio 3 times less likely to have high grade prostate cancer</title><link>/posts/men-with-high-omega-3-ratio-3-times-less-likely-to-have-high-grade-prostate-cancer.html</link><pubDate>Sat, 20 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/men-with-high-omega-3-ratio-3-times-less-likely-to-have-high-grade-prostate-cancer.html</guid><description>&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/breast-cancer-reduced-20-percent-by-fish-omega-3-meta-analysis">Breast Cancer reduced 20 percent by fish (Omega-3) – meta-analysis Feb 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/omega-3-reduces-side-effects-of-cancer-treatments">Omega-3 reduces side effects of Cancer treatments – April 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/omega-3-prevents-and-treats-several-cancers">Omega-3 prevents and treats several cancers – Sept 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/pancreatic-cancer-is-increasing-vitamin-d-and-omega-3-should-reduce-the-risk">Pancreatic Cancer is increasing – Vitamin D and Omega-3 should reduce the risk&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/omega-3-should-help-pancreatic-cancer-in-5-ways">Omega-3 should help Pancreatic Cancer in 5 ways – June 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/prostate-cancer-treatment-vitamin-d-omega-3-tumeric-rct-ending">Prostate Cancer treatment (Vitamin D, Omega-3, Tumeric) RCT ending Dec 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/prostate-cancer-omega-3.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Prostate cancer 3X more likely to be lethal if both low vitamin D and poor Vitamin D Binding gene</title><link>/posts/prostate-cancer-3x-more-likely-to-be-lethal-if-both-low-vitamin-d-and-poor-vitamin-d-binding-gene.html</link><pubDate>Thu, 11 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-3x-more-likely-to-be-lethal-if-both-low-vitamin-d-and-poor-vitamin-d-binding-gene.html</guid><description/></item><item><title>The use of Vitamin D to prevent prostate cancer doubled in a decade</title><link>/posts/the-use-of-vitamin-d-to-prevent-prostate-cancer-doubled-in-a-decade.html</link><pubDate>Thu, 16 May 2019 00:00:00 +0000</pubDate><guid>/posts/the-use-of-vitamin-d-to-prevent-prostate-cancer-doubled-in-a-decade.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#trends-in-complementary-and-alternative-medicine-use-among-patients-with-prostate-cancer">Trends in complementary and alternative medicine use among patients with prostate cancer.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#increased-use-of-vitamin-d">Increased use of Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#study-had-been-cited-14-times-as-of-march-2024">Study had been cited 14 times as of March 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="trends-in-complementary-and-alternative-medicine-use-among-patients-with-prostate-cancer">Trends in complementary and alternative medicine use among patients with prostate cancer.&lt;/h4>
&lt;p>J Urol. 2019 May 15 &lt;a href="https://doi.org/10.1097/JU.0000000000000336">doi: 10.1097/JU.0000000000000336&lt;/a>&lt;/p>
&lt;p>Zuniga KB1,2, Zhao S3, Kenfield SA3, Cedars B4, Cowan JE3, Van Blarigan EL3,5, Broering JM3, Carroll PR3, Chan JM3,5.&lt;/p>
&lt;p>PURPOSE:&lt;/p>
&lt;p>To explore prevalence and trends of self-reported complementary and alternative medicine (CAM) use among patients with prostate cancer (PCa) using the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURETM).&lt;/p></description></item><item><title>Variety of Vitamin D forms treat Prostate Cancer – RCT Review</title><link>/posts/variety-of-vitamin-d-forms-treat-prostate-cancer-rct-review.html</link><pubDate>Wed, 01 May 2019 00:00:00 +0000</pubDate><guid>/posts/variety-of-vitamin-d-forms-treat-prostate-cancer-rct-review.html</guid><description/></item><item><title>Chemo only as needed for Prostate Cancer is working well</title><link>/posts/chemo-only-as-needed-for-prostate-cancer-is-working-well.html</link><pubDate>Thu, 28 Mar 2019 00:00:00 +0000</pubDate><guid>/posts/chemo-only-as-needed-for-prostate-cancer-is-working-well.html</guid><description>&lt;h4 id="a-clever-new-strategy-for-treating-cancer-thanks-to-darwinhttpswwwwiredcomstorycancer-treatment-darwin-evolution-wired-magazine">&lt;a href="https://www.wired.com/story/cancer-treatment-darwin-evolution/">A CLEVER NEW STRATEGY FOR TREATING CANCER, THANKS TO DARWIN&lt;/a> Wired Magazine&lt;/h4>
&lt;p>&lt;strong>Do not try to kill Prostate Cancer, but just keep it contained - dose only when needed&lt;/strong>&lt;/p>
&lt;p>Constant dosing and the cancer evolves how to avoid the chemotherapy (carpet bombing)&lt;/p>
&lt;p>war analogy - constant bombing and the enemy evolves a defense - bumkers&lt;/p>
&lt;p>with infrequent dosing it does not have evolutionary pressure to learn from&lt;/p>
&lt;p>classic example of the math that plotted how growing populations of snowshoe hares fuel the rise of the lynx that feed on them&lt;/p></description></item><item><title>Rates of some newly diagnosed Cancers increased with higher Vitamin D (217,000 Danes)</title><link>/posts/rates-of-some-newly-diagnosed-cancers-increased-with-higher-vitamin-d-217000-danes.html</link><pubDate>Tue, 08 Jan 2019 00:00:00 +0000</pubDate><guid>/posts/rates-of-some-newly-diagnosed-cancers-increased-with-higher-vitamin-d-217000-danes.html</guid><description/></item><item><title>Better Cancer survival if higher vitamin D a decade earlier (esp. Melanoma, Kidney, Prostate)</title><link>/posts/better-cancer-survival-if-higher-vitamin-d-a-decade-earlier-esp-melanoma-kidney-prostate.html</link><pubDate>Tue, 20 Nov 2018 00:00:00 +0000</pubDate><guid>/posts/better-cancer-survival-if-higher-vitamin-d-a-decade-earlier-esp-melanoma-kidney-prostate.html</guid><description/></item><item><title>Prostate Cancer death 40 percent less likely if 40 ng level of vitamin D – Meta-analysis</title><link>/posts/prostate-cancer-death-40-percent-less-likely-if-40-ng-level-of-vitamin-d-meta-analysis.html</link><pubDate>Sat, 13 Oct 2018 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-death-40-percent-less-likely-if-40-ng-level-of-vitamin-d-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#circulating-vitamin-d-level-and-mortality-in-prostate-cancer-patients-a-dose-response-meta-analysis---oct-2018">Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis - Oct 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#24-x-more-likely-to-die-of-prostate-cancer-if-low-vitamin-d---oct-2020">2.4 X more likely to die of Prostate Cancer if low Vitamin D - Oct 2020&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="circulating-vitamin-d-level-and-mortality-in-prostate-cancer-patients-a-dose-response-meta-analysis---oct-2018">Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis - Oct 2018&lt;/h4>
&lt;p>Endocrine Connections DOI: &lt;a href="https://doi.org/10.1530/EC-18-0283">https://doi.org/10.1530/EC-18-0283&lt;/a>&lt;/p>
&lt;p>Zhenyu Song 1 , Qiuming Yao 2 , Zhiyuan Zhuo 3 , Zhe Ma 4 and Gang Chen 5 &lt;a href="mailto:chgan305@163.com">chgan305@163.com&lt;/a>&lt;/p></description></item><item><title>Low-Grade Prostate Cancer 70 percent less likely to progress if good level of Omega-3</title><link>/posts/low-grade-prostate-cancer-70-percent-less-likely-to-progress-if-good-level-of-omega-3.html</link><pubDate>Tue, 10 Apr 2018 00:00:00 +0000</pubDate><guid>/posts/low-grade-prostate-cancer-70-percent-less-likely-to-progress-if-good-level-of-omega-3.html</guid><description/></item><item><title>Prostate cancer risk increase with Vitamin D (other studies disagree) – meta-analysis</title><link>/posts/prostate-cancer-risk-increase-with-vitamin-d-other-studies-disagree-meta-analysis.html</link><pubDate>Thu, 11 Jan 2018 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-risk-increase-with-vitamin-d-other-studies-disagree-meta-analysis.html</guid><description/></item><item><title>Prostate Cancer might be treated by 4,000 IU of vitamin D and aspirin – RCT 2021</title><link>/posts/prostate-cancer-might-be-treated-by-4000-iu-of-vitamin-d-and-aspirin-rct-2021.html</link><pubDate>Tue, 28 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-might-be-treated-by-4000-iu-of-vitamin-d-and-aspirin-rct-2021.html</guid><description>&lt;h4 id="a-study-to-examine-the-effectiveness-of-aspirin-andor-vitamin-d3-to-prevent-prostate-cancer-progression-proventhttpsclinicaltrialsgovct2shownct03103152titlesproventrank1">&lt;a href="https://clinicaltrials.gov/ct2/show/NCT03103152?titles=provent&amp;amp;rank=1">A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression (PROVENT)&lt;/a>&lt;/h4>
&lt;p>12 months with 4,000 IU of vitamin D and 400 mg of Aspirin&lt;/p>
&lt;p>Estimated Study Completion Date:	October 2019&lt;/p></description></item><item><title>Prostate Cancer risk in black men increased 2X having poor Vitamin D Binding Protein</title><link>/posts/prostate-cancer-risk-in-black-men-increased-2x-having-poor-vitamin-d-binding-protein.html</link><pubDate>Sun, 19 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-risk-in-black-men-increased-2x-having-poor-vitamin-d-binding-protein.html</guid><description>&lt;h4 id="serum-25-hydroxyvitamin-d-vitamin-d-binding-protein-and-prostate-cancer-risk-in-black-men">Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.&lt;/h4>
&lt;p>Cancer. 2017 Jul 15;123(14):2698-2704. &lt;a href="https://doi.org/10.1002/cncr.30634.">doi: 10.1002/cncr.30634.&lt;/a> Epub 2017 Apr 3.&lt;/p>
&lt;p>Layne TM1,2, Weinstein SJ2, Graubard BI2, Ma X1,3, Mayne ST1,3, Albanes D2.&lt;/p>
&lt;p>1 Chronic Disease Epidemiology Department, Yale School of Public Health, New Haven, Connecticut.&lt;/p>
&lt;p>2 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.&lt;/p>
&lt;p>3 Yale Comprehensive Cancer Center, Yale University, New Haven, Connecticut.&lt;/p></description></item><item><title>Prostate Cancer treatment (Vitamin D, Omega-3, Tumeric) RCT ending</title><link>/posts/prostate-cancer-treatment-vitamin-d-omega-3-tumeric-rct-ending.html</link><pubDate>Mon, 25 Sep 2017 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-treatment-vitamin-d-omega-3-tumeric-rct-ending.html</guid><description/></item><item><title>Prostate and Urinary systems much better with higher vitamin D – many studies</title><link>/posts/prostate-and-urinary-systems-much-better-with-higher-vitamin-d-many-studies.html</link><pubDate>Thu, 29 Jun 2017 00:00:00 +0000</pubDate><guid>/posts/prostate-and-urinary-systems-much-better-with-higher-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prostate-volume-and-urinary-system-much-better-with-even-28-ng-of-vitamin-d--april-2017">Prostate volume and urinary system much better with even 28 ng of vitamin D – April 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bph-52-x-more-likely-if-low-vitamin-d--nov-2016">BPH 5.2 X more likely if low vitamin D – Nov 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#urinary-tract-infection-40-less-likely-if-man-has-a-good-vitamin-d-receptor--meta-analysis-oct-2014">Urinary tract infection 40% less likely if man has a good Vitamin D receptor – Meta-analysis Oct 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bph-decreased-by-3-with-6000-iu-vitamin-d-analogs-for-10-months-dec-2013">BPH decreased (by 3%) with 6,000 IU Vitamin D analogs for 10 months– Dec 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#urinary-incontinence-32x-less-likely-in-elderly-if-ok-level-of-vitamin-d--sept-2016">Urinary incontinence 3.2X less likely in elderly if OK level of vitamin D – Sept 2016&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/uti-associated-with-low-vitamin-d-as-well-as-treated-many-studies">UTI associated with low Vitamin D as well as treated - many studies&lt;/a>&lt;/p></description></item><item><title>Prostate surgery outcomes vary with Vitamin D Receptors</title><link>/posts/prostate-surgery-outcomes-vary-with-vitamin-d-receptors.html</link><pubDate>Fri, 16 Jun 2017 00:00:00 +0000</pubDate><guid>/posts/prostate-surgery-outcomes-vary-with-vitamin-d-receptors.html</guid><description/></item><item><title>Prostate cancer in black men is 1.6 times more likely if a poor Vitamin D Receptor</title><link>/posts/prostate-cancer-in-black-men-is-16-times-more-likely-if-a-poor-vitamin-d-receptor.html</link><pubDate>Mon, 06 Mar 2017 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-in-black-men-is-16-times-more-likely-if-a-poor-vitamin-d-receptor.html</guid><description/></item><item><title>Aggressive Prostate Cancer in blacks with low vitamin D – 7X more likely if added Calcium</title><link>/posts/aggressive-prostate-cancer-in-blacks-with-low-vitamin-d-7x-more-likely-if-added-calcium.html</link><pubDate>Wed, 28 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/aggressive-prostate-cancer-in-blacks-with-low-vitamin-d-7x-more-likely-if-added-calcium.html</guid><description/></item><item><title>High PSA readings with Prostate Cancer 4 times more likely if poor Vitamin D receptor</title><link>/posts/high-psa-readings-with-prostate-cancer-4-times-more-likely-if-poor-vitamin-d-receptor.html</link><pubDate>Sun, 13 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/high-psa-readings-with-prostate-cancer-4-times-more-likely-if-poor-vitamin-d-receptor.html</guid><description/></item><item><title>Higher rate of prostate cancer in AA may decrease if take vitamin D</title><link>/posts/higher-rate-of-prostate-cancer-in-aa-may-decrease-if-take-vitamin-d.html</link><pubDate>Thu, 07 Jul 2016 00:00:00 +0000</pubDate><guid>/posts/higher-rate-of-prostate-cancer-in-aa-may-decrease-if-take-vitamin-d.html</guid><description>&lt;h4 id="can-vitamin-d-supplementation-reduce-prostate-cancer-disparities">Can vitamin D supplementation reduce prostate cancer disparities?&lt;/h4>
&lt;p>Pharmacogenomics. 2016 Jul 6. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Batai K1, Kittles RA1. &lt;a href="mailto:rkittles@email.arizona.edu">rkittles@email.arizona.edu&lt;/a>&lt;/p>
&lt;p>1Division of Urology, Department of Surgery, The University of Arizona, Tucson, AZ, USA.&lt;/p>
&lt;p>&lt;strong>NO ABSTRACT&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/can-vitamin-d-supplementation-reduce-pc-disparities.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>PMID: 27380910&lt;/p></description></item><item><title>Vitamin D review of Colorectal, Breast, and Prostate Cancers</title><link>/posts/vitamin-d-review-of-colorectal-breast-and-prostate-cancers.html</link><pubDate>Sun, 05 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-review-of-colorectal-breast-and-prostate-cancers.html</guid><description/></item><item><title>Radical Prostatectomy problems 2.6X more likely if low vitamin D</title><link>/posts/radical-prostatectomy-problems-26x-more-likely-if-low-vitamin-d.html</link><pubDate>Sat, 27 Feb 2016 00:00:00 +0000</pubDate><guid>/posts/radical-prostatectomy-problems-26x-more-likely-if-low-vitamin-d.html</guid><description>&lt;h4 id="associations-between-serum-vitamin-d-and-adverse-pathology-in-men-undergoing-radical-prostatectomy">Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.&lt;/h4>
&lt;p>J Clin Oncol. 2016 Feb 22. pii: JCO651463. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Nyame YA1, Murphy AB2, Bowen DK1, Jordan G1, Batai K1, Dixon M1, Hollowell CM1, Kielb S1, Meeks JJ1, Gann PH1, Macias V1, Kajdacsy-Balla A1, Catalona WJ1, Kittles R1.&lt;/p>
&lt;p>1Yaw A. Nyame, Cleveland Clinic, Cleveland, Ohio; Adam B. Murphy, Diana K. Bowen, Gregory Jordan, Michael Dixon, Stephanie Kielb, Joshua J. Meeks, and William J. Catalona, Northwestern University, Chicago; Courtney M.P. Hollowell, Cook County Health and Hospitals System; Peter H. Gann, Virgilia Macias, and Andre Kajdacsy-Balla, University of Illinois at Chicago, Chicago, IL; and Ken Batai and Rick Kittles, University of Arizona, Tucson, AZ.&lt;/p></description></item><item><title>Prostate Cancer long term survival 1.7 X more likely if high level of vitamin D</title><link>/posts/prostate-cancer-long-term-survival-17-x-more-likely-if-high-level-of-vitamin-d.html</link><pubDate>Wed, 27 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-long-term-survival-17-x-more-likely-if-high-level-of-vitamin-d.html</guid><description>&lt;h4 id="circulating-25-hydroxyvitamin-d-and-prostate-cancer-survival">Circulating 25-hydroxyvitamin D and prostate cancer survival.&lt;/h4>
&lt;p>Cancer Epidemiol Biomarkers Prev. 2016 Jan 25. pii: cebp.0991.2015. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Mondul AM 1, Weinstein SJ 2, Moy KA 3, Mannisto S 4, Albanes D 2.&lt;/p>
&lt;p>1Department of Epidemiology, University of Michigan School of Public health &lt;a href="mailto:amondul@umich.edu">amondul@umich.edu&lt;/a>.&lt;/p>
&lt;p>2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health.&lt;/p>
&lt;p>3National Cancer Institute.&lt;/p>
&lt;p>4Department of Chronic Disease Prevention, National Institute for Health and Welfare.&lt;/p></description></item><item><title>Aggressive Prostate Cancer increased by Calcium but decreased by Vitamin D (genes too)</title><link>/posts/aggressive-prostate-cancer-increased-by-calcium-but-decreased-by-vitamin-d-genes-too.html</link><pubDate>Tue, 06 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/aggressive-prostate-cancer-increased-by-calcium-but-decreased-by-vitamin-d-genes-too.html</guid><description>&lt;h4 id="association-of-calcium-and-vitamin-d-intake-and-vitamin-d-receptor-genotypes-with-prostate-cancer-in-multiethnic-samples">Association of calcium and vitamin D intake and vitamin D receptor genotypes with prostate cancer in multiethnic samples&lt;/h4>
&lt;p>Abstracts: Seventh AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 9-12, 2014; San Antonio, TX&lt;/p>
&lt;p>Cancer Epidemiol Biomarkers Prev October 2015 24; B16, &lt;a href="https://doi.org/10.1158/1538-7755.DISP14-B16">doi: 10.1158/1538-7755.DISP14-B16&lt;/a>&lt;/p>
&lt;p>Ken Batai1, Adam B. Murphy2, Ebony Shah1, Maria Ruden3, Jennifer Newsome4, Michael A. Dixon2, Ahaghotu Chiledum5, and Rick A. Kittles1&lt;/p></description></item><item><title>Prostate Cancer incidence and death 2X more often among black men (vitamin D not mentioned)</title><link>/posts/prostate-cancer-incidence-and-death-2x-more-often-among-black-men-vitamin-d-not-mentioned.html</link><pubDate>Thu, 30 Jul 2015 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-incidence-and-death-2x-more-often-among-black-men-vitamin-d-not-mentioned.html</guid><description>&lt;h4 id="lifetime-risk-of-being-diagnosed-with-or-dying-from-prostate-cancer-by-major-ethnic-group-in-england-20082010">Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010&lt;/h4>
&lt;p>BMC Medicine 2015, 13:171 doi:10.1186/s12916-015-0405-5&lt;/p>
&lt;p>Therese Lloyd1, Luke Hounsome2, Anita Mehay1, Sarah Mee1, Julia Verne2 and Alison Cooper1 &lt;a href="mailto:evidence@prostatecanceruk.org">evidence@prostatecanceruk.org&lt;/a>&lt;/p>
&lt;p>1 Evidence Team, Prostate Cancer UK, 4th Floor Counting House, 53 Tooley Street, London, UK&lt;/p>
&lt;p>2 Knowledge and Intelligence Team (South West), Public Health England, 2 Rivergate, Temple Quay, Bristol, UK&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>In the UK, a man’s lifetime risk of being diagnosed with prostate cancer is 1 in 8. We calculated both the lifetime risk of being diagnosed with and dying from prostate cancer by major ethnic group.&lt;/p></description></item><item><title>Prostate problem (BPH) reduced by herbs, Zinc, Vitamin D etc.</title><link>/posts/prostate-problem-bph-reduced-by-herbs-zinc-vitamin-d-etc.html</link><pubDate>Sat, 04 Jul 2015 00:00:00 +0000</pubDate><guid>/posts/prostate-problem-bph-reduced-by-herbs-zinc-vitamin-d-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#how-the-herbs-help---nov-2014">How the herbs help - Nov 2014&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#saw-palmetto-been-used-for-span-stylecolorf062000-yearsspan">Saw Palmetto (been used for &lt;span style="color:#F06;">2000+ years&lt;/span>)&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#jama---1998-similar-to-finastreride-with-fewer-adverse-events">JAMA - 1998: similar to finastreride, with fewer adverse events&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#zdravniški-vestnik---2014-efficacy-70">Zdravniški Vestnik - 2014: efficacy 70%&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pharmacy--pharmacology-international-journal---dec-2014-appears-to-be-effective">Pharmacy &amp;amp; Pharmacology International Journal - Dec 2014: appears to be effective&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#video-review-of-bph-supplements-some-do-not-contain-as-much-as-claimed---sept-2024">Video review of BPH supplements (some do not contain as much as claimed - Sept 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#examinecom-unsure">Examine.com unsure&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#pygeum-been-used-by-whites-for-span-stylecolorf00300-yearsspan">Pygeum (been used by whites for &lt;span style="color:#F00;">300+ years&lt;/span>)&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#europe-1998-multicenter-trial">Europe 1998 multicenter trial&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#examinecom--20-reduction">Examine.com -~20% reduction&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#beta-sitosterol-an-active-ingredient-of-pygeum">Beta Sitosterol (an active ingredient of Pygeum)&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#life-extension-foundation---2005">Life Extension Foundation - 2005&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cochrane---july-1999-it-works">Cochrane - July 1999 It works&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#a-review-on-pumpkin-seeds-in-promoting-prostate-health---2022">A REVIEW ON PUMPKIN SEEDS IN PROMOTING PROSTATE HEALTH - 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#perhaps-vitamin-k2-already-taking-it">Perhaps Vitamin K2 (already taking it)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#benign-prostate-hyperplasia-and-nutrition-zinc-and-vitamin-d-and-supplements-like-saw-palmetto-etc-2019">Benign prostate hyperplasia and nutrition (zinc and Vitamin D, and supplements like Saw palmetto, etc) 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#age-related-changes-in-zinc-copper-and-selenium-levels-in-the-human-prostate---april-2021">Age-Related Changes in Zinc, Copper and Selenium Levels in the Human Prostate - April 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#zinc-to-shrink-your-prostate">Zinc to shrink your prostate&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#zinc-in-prostate-health-and-disease-a-mini-review---dec-2022">Zinc in Prostate Health and Disease: A Mini Review - Dec 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h2 id="how-the-herbs-help---nov-2014">How the herbs help - Nov 2014&lt;/h2>
&lt;p>&lt;strong>&lt;a href="http://austinpublishinggroup.com/nutrition-food-sciences/fulltext/ajnfs-v2-id1054.php">The Pharmacological Effects of Natural Products and Herbs in Benign Prostatic Hyperplasia&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Prostate cancer reduced when 4000 IU vitamin D was added– Hollis RCT</title><link>/posts/prostate-cancer-reduced-when-4000-iu-vitamin-d-was-added-hollis-rct.html</link><pubDate>Thu, 02 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-reduced-when-4000-iu-vitamin-d-was-added-hollis-rct.html</guid><description>&lt;h4 id="online-first-evidence-that-vitamin-d-can-slow-or-reverse-low-grade-prostate-cancer">ONLINE FIRST: Evidence that Vitamin D Can Slow or Reverse Low-Grade Prostate Cancer&lt;/h4>
&lt;p>&lt;a href="http://journals.lww.com/oncology-times/blog/asco11spotlightnews/pages/post.aspx?PostID=265">Oncology times&lt;/a>&lt;/p>
&lt;p>BY KURT SAMSON&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>Hollis would recommend 6,000 to 8,000 units of supplementary vitamin D for most adults as a preventive measure to reduce inflammation&lt;/p>
&lt;p>&lt;strong>See also VitaminDWiki&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-prostate-cancer-and-vitamin-d">Overview Prostate Cancer and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-deficiency-predicts-prostate-biopsy-outcomes">Vitamin D deficiency predicts prostate biopsy outcomes – May 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/prostate-cancer-in-veterans-more-survivable-when-have-enough-vitamin-d">Prostate cancer in veterans more survivable when have enough vitamin D – Jan 2014&lt;/a>&lt;/p></description></item><item><title>Prostate Cancer – 300,000 annual deaths, low vitamin D is one of many factors – current status</title><link>/posts/prostate-cancer-300000-annual-deaths-low-vitamin-d-is-one-of-many-factors-current-status.html</link><pubDate>Thu, 26 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-300000-annual-deaths-low-vitamin-d-is-one-of-many-factors-current-status.html</guid><description>&lt;h3 id="epidemiology-of-prostate-cancer-current-status">Epidemiology of prostate cancer: current status.&lt;/h3>
&lt;p>Eur Rev Med Pharmacol Sci. 2015 Mar;19(5):805-812.&lt;/p>
&lt;p>Tao ZQ1, Shi AM, Wang KX, Zhang WD.&lt;/p>
&lt;p>1Department of Science and Education, Xuzhou Central Hospital, Xuzhou, Jiangsu, China. &lt;a href="mailto:taoziqi@163.com">taoziqi@163.com&lt;/a>.&lt;/p>
&lt;p>Prostate cancer is one of the most common cancers affecting men with &amp;gt; 1,100,000 new cases and 300,000 deaths worldwide each year. The disease is more common among older men, with a median age at diagnosis around age above 60 years. Prostate cancer is a major medical problem that needs immediate attention as the disease is indolent, shows prolonged latency in association with high morbidity and mortality. Administration of diagnostic tests including PSA test and biopsies and the advances in other diagnostic procedures have led to early detection of the disease with therapeutic steps being taken early on, there has been a steady decline in the disease-specific mortality. Global incidence and mortality rates show that the disease is &lt;strong>more prevalent among black people,&lt;/strong> even though the differences cannot be attributed entirely to race, as the influence of socioeconomic situation and the resultant limited access to medical technologies and treatment could not be ruled out completely. Several genes have been identified that when mutated confer high risk for the disease. Besides the genetic factors, family history and nutritional factors such as lack of enough vitamin D, high intake of calcium, &lt;strong>obesity&lt;/strong> and high fat diets have been implicated as risk factors for prostate cancer. Therapeutic measures for prostate cancer involve mostly radical prostatectomy followed by radiotherapy in combination with hormonal treatment as needed.&lt;/p></description></item><item><title>Hypothesis: Vitamin K will reduce prostate blood vessel problems</title><link>/posts/hypothesis-vitamin-k-will-reduce-prostate-blood-vessel-problems.html</link><pubDate>Fri, 13 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/hypothesis-vitamin-k-will-reduce-prostate-blood-vessel-problems.html</guid><description>&lt;h4 id="vitamin-k-the-missing-link-to-prostate-health">Vitamin K: The missing link to prostate health&lt;/h4>
&lt;p>Medical Hypothesis DOI: &lt;a href="http://dx.doi.org/10.1016/j.mehy.2014.12.028">http://dx.doi.org/10.1016/j.mehy.2014.12.028&lt;/a>&lt;/p>
&lt;p>Michael S. Donaldson &lt;a href="mailto:mdonaldson@hacres.com">mdonaldson@hacres.com&lt;/a>&lt;/p>
&lt;p>Hallelujah Acres, 1733 Cutler Way, Zillah, WA 98953, United States&lt;/p>
&lt;p>Received: July 21, 2014; Accepted: December 28, 2014; Published Online: January 19, 2015&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=%22varicose+veins%22&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for &lt;strong>&amp;ldquo;VARICOSE VEINS&amp;rdquo;&lt;/strong> &lt;/a> 39 items as of Feb 2020&lt;/p>
&lt;ul>
&lt;li>Note: Search Google for &amp;ldquo;varicose veins&amp;rdquo; &amp;ldquo;vitamin k&amp;rdquo; gets 270,000 hits as of Feb 2020&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-vitamin-k-and-vitamin-d">Overview Vitamin K and Vitamin D&lt;/a>&lt;/p></description></item><item><title>Vitamin D deficiency predicts prostate biopsy outcomes</title><link>/posts/vitamin-d-deficiency-predicts-prostate-biopsy-outcomes.html</link><pubDate>Wed, 07 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-predicts-prostate-biopsy-outcomes.html</guid><description>&lt;p>Clin Cancer Res. 2014 May 1;20(9):2289-99. &lt;a href="https://doi.org/10.1158/1078-0432.CCR-13-3085.">doi: 10.1158/1078-0432.CCR-13-3085.&lt;/a>&lt;/p>
&lt;p>Murphy AB1, Nyame Y, Martin IK, Catalona WJ, Hollowell CM, Nadler RB, Kozlowski JM, Perry KT, Kajdacsy-Balla A, Kittles R.&lt;/p>
&lt;p>PURPOSE:&lt;/p>
&lt;p>The association between vitamin D and prostate biopsy outcomes has not been evaluated. We examine serum vitamin D levels with prostate biopsy results in men with an abnormal prostate-specific antigen and/or digital rectal examination.&lt;/p>
&lt;p>EXPERIMENTAL DESIGN:&lt;/p>
&lt;p>Serum 25-hydroxyvitamin D (25-OH D) was obtained from 667 men, ages 40 to 79 years, prospectively enrolled from Chicago urology clinics undergoing first prostate biopsy. Logistic regression was used to evaluate the associations between 25-OH D status and incident prostate cancer, Gleason score, and tumor stage.&lt;/p></description></item><item><title>Tanning potential predicts risk of Prostate Cancer in Blacks</title><link>/posts/tanning-potential-predicts-risk-of-prostate-cancer-in-blacks.html</link><pubDate>Sun, 16 Nov 2014 00:00:00 +0000</pubDate><guid>/posts/tanning-potential-predicts-risk-of-prostate-cancer-in-blacks.html</guid><description>&lt;h3 id="use-of-tanning-potential-as-a-predictor-for-prostate-cancer-risk-in-african-american-men">Use of Tanning Potential as a Predictor for Prostate Cancer Risk in African-American Men.&lt;/h3>
&lt;p>In Vivo. 2014 11-12;28(6):1181-1187.&lt;/p>
&lt;p>Beyene D1, Daremipouran M1, Apprey V2, Williams R3, Ricks-Santi L4, Kassim OO5, Naab TJ6, Kanaan YM7, Copeland RL Jr8.&lt;/p>
&lt;p>1Howard University Cancer Center, College of Medicine, Howard University, Washington, DC, U.S.A.&lt;/p>
&lt;p>2National Human Genome Center, College of Medicine, Howard University, Washington, DC, U.S.A. Community and Family Medicine, College of Medicine, Howard University, Washington, DC, U.S.A.&lt;/p></description></item><item><title>PSA levels in blacks were not changed by 3 months of 4,000 IU of vitamin D (not enough)</title><link>/posts/psa-levels-in-blacks-were-not-changed-by-3-months-of-4000-iu-of-vitamin-d-not-enough.html</link><pubDate>Sat, 02 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/psa-levels-in-blacks-were-not-changed-by-3-months-of-4000-iu-of-vitamin-d-not-enough.html</guid><description>&lt;h3 id="null-association-between-vitamin-d-and-psa-levels-among-black-men-in-a-vitamin-d-supplementation-trial">Null Association Between Vitamin D and PSA Levels Among Black Men in a Vitamin D Supplementation Trial&lt;/h3>
&lt;p>Cancer Epidemiology, Biomarkers &amp;amp; Prevention June 2014&lt;/p>
&lt;p>Paulette D. Chandler1,*, Edward L. Giovannucci2, Jamil B. Scott3, Gary G. Bennett4, Kimmie Ng5, Andrew T. Chan6, Bruce W. Hollis7, Karen M. Emmons8, Charles S. Fuchs9, and Bettina F. Drake10&lt;/p>
&lt;p>1Preventive Medicine, Brigham and Women&amp;rsquo;s Hospital&lt;/p>
&lt;p>2Departments of Epidemiology &amp;amp; Nutrition, Harvard School of Public Health&lt;/p></description></item><item><title>Prostate cancer in veterans more survivable when have enough vitamin D</title><link>/posts/prostate-cancer-in-veterans-more-survivable-when-have-enough-vitamin-d.html</link><pubDate>Fri, 10 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-in-veterans-more-survivable-when-have-enough-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-and-prostate-cancer-survival-in-veterans">Vitamin d and prostate cancer survival in veterans.&lt;/h2>
&lt;p>Mil Med. 2014 Jan;179(1):81-4. &lt;a href="https://doi.org/10.7205/MILMED-D-12-00540.">doi: 10.7205/MILMED-D-12-00540.&lt;/a>&lt;/p>
&lt;p>Der T 1, Bailey BA 2, Youssef D 1, Manning T 3, Grant WB 4, Peiris AN 1.&lt;/p>
&lt;p>1 Department of Internal Medicine, East Tennessee State University, P.O. Box 70622, Johnson City, TN 37614.&lt;/p>
&lt;p>2 Department Family Medicine, East Tennessee State University, P.O. Box 70621, Johnson City, TN 37614.&lt;/p>
&lt;p>3 Mountain Home VAMC, Mountain Home, TN 37684.&lt;/p></description></item><item><title>Vitamin D proven to treat or prevent many cancers in animals, but only breast cancer in humans so far</title><link>/posts/vitamin-d-proven-to-treat-or-prevent-many-cancers-in-animals-but-only-breast-cancer-in-humans-so-far.html</link><pubDate>Fri, 10 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-proven-to-treat-or-prevent-many-cancers-in-animals-but-only-breast-cancer-in-humans-so-far.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#references">References&lt;/a>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#chen-abstract">Chen Abstract&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h1 id="vitamin-d-and-cancer-the-promise-not-yet-fulfilled">Vitamin D and cancer: the promise not yet fulfilled&lt;/h1>
&lt;p>Endocrine. 2014 Jan 9.&lt;/p>
&lt;p>Bikle DD.&lt;/p>
&lt;p>The negative association of the latitude where people live and the incidence of non cutaneous cancer in that population in North America have been demonstrated in many studies for many types of cancer. Since the intensity of UVB exposure decreases with increasing latitude, and UVB exposure provides the mechanism for vitamin D production in the skin, the hypothesis that increased vitamin D provides protection against the development of cancer has been proposed. This hypothesis has been tested in a substantial number of prospective and case control studies and in a few randomized clinical trials (RTC) assessing whether either vitamin D intake or serum levels of 25 hydroxyvitamin D (25OHD) correlate (inversely) with cancer development. Most of the studies have focused on colorectal, breast, and prostate cancer. The results have been mixed. The most compelling data for a beneficial relationship between vitamin D intake or serum 25OHD levels and cancer have been obtained for colorectal cancer.&lt;/p></description></item><item><title>Prostate Cancer increased melanoma rate by 2X (vitamin D not mentioned)</title><link>/posts/prostate-cancer-increased-melanoma-rate-by-2x-vitamin-d-not-mentioned.html</link><pubDate>Sat, 09 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-increased-melanoma-rate-by-2x-vitamin-d-not-mentioned.html</guid><description>&lt;h3 id="personal-history-of-prostate-cancer-and-increased-risk-of-incident-melanoma-in-the-united-states">Personal History of Prostate Cancer and Increased Risk of Incident Melanoma in the United States&lt;/h3>
&lt;p>Journal of Clinical Oncology November 4, 2013, &lt;a href="https://doi.org/10.1200/JCO.2013.51.1915">doi: 10.1200/JCO.2013.51.1915&lt;/a>&lt;/p>
&lt;p>Wen-Qing Li, Abrar A. Qureshi, Jing Ma, Alisa M. Goldstein, Edward L. Giovannucci, Meir J. Stampfer and Jiali Han⇑&lt;/p>
&lt;p>Wen-Qing Li and Alisa M. Goldstein, National Cancer Institute, National Institutes of Health, Rockville, MD; Wen-Qing Li, Abrar A. Qureshi, Jing Ma, Edward L. Giovannucci, Meir J. Stampfer, and Jiali Han, Brigham and Women’s Hospital, Harvard Medical School; Edward L. Giovannucci and Meir J. Stampfer, Harvard School of Public Health, Boston, MA; Jiali Han, Richard M. Fairbanks School of Public Health, Simon Cancer Center, Indiana University, Indianapolis, IN; and Jiali Han, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.&lt;/p></description></item><item><title>People more likely to freckle are more likely to get prostate cancer (low vitamin D)</title><link>/posts/people-more-likely-to-freckle-are-more-likely-to-get-prostate-cancer-low-vitamin-d.html</link><pubDate>Fri, 01 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/people-more-likely-to-freckle-are-more-likely-to-get-prostate-cancer-low-vitamin-d.html</guid><description>&lt;h4 id="using-genetic-proxies-for-lifecourse-sun-exposure-to-assess-the-causal-relationship-of-sun-exposure-with-circulating-vitamin-d-and-prostate-cancer-risk">Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.&lt;/h4>
&lt;p>Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):597-606. &lt;a href="https://doi.org/10.1158/1055-9965.EPI-12-1248.">doi: 10.1158/1055-9965.EPI-12-1248.&lt;/a> Epub 2013 Feb 25.&lt;/p>
&lt;p>Bonilla C, Gilbert R, Kemp JP, Timpson NJ, Evans DM, Donovan JL, Hamdy FC, Neal DE, Fraser WD, Davey SG, Lewis SJ, Lathrop M, Martin RM.&lt;/p>
&lt;p>School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom.&lt;/p></description></item><item><title>Molecular Link between Vitamin D and Cancer Prevention</title><link>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</link><pubDate>Wed, 02 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/molecular-link-between-vitamin-d-and-cancer-prevention.html</guid><description>&lt;p>Nutrients 2013, 5(10), 3993-4021; doi:10.3390/nu5103993&lt;/p>
&lt;p>Meis Moukayed 1email and William B. Grant 2,* email&lt;/p>
&lt;p>1 School of Arts and Sciences, American University in Dubai, P. O. Box 28282, Dubai, UAE&lt;/p>
&lt;p>2 Sunlight, Nutrition, and Health Research Center, San Francisco, CA 94164-1603, USA&lt;/p>
&lt;ul>
&lt;li>Author to whom correspondence should be addressed.&lt;/li>
&lt;/ul>
&lt;p>Received: 7 August 2013; in revised form: 11 September 2013 / Accepted: 18 September 2013 / Published: 30 September 2013&lt;/p>
&lt;p>(This article belongs to the Special Issue Vitamin D and Human Health)&lt;/p></description></item><item><title>Prostate volume decreases with vitamin D supplementation</title><link>/posts/prostate-volume-decreases-with-vitamin-d-supplementation.html</link><pubDate>Tue, 13 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/prostate-volume-decreases-with-vitamin-d-supplementation.html</guid><description>&lt;h2 id="vitamin-d-and-benign-prostatic-hyperplasia---a-review">Vitamin D and benign prostatic hyperplasia - a review.&lt;/h2>
&lt;p>Can J Urol. 2013 Aug;20(4):6820-5.&lt;/p>
&lt;p>Espinosa G, Esposito R, Kazzazi A, Djavan B.&lt;/p>
&lt;p>New York University School of Medicine, New York, New York, USA.&lt;/p>
&lt;p>INTRODUCTION: Benign prostatic hyperplasia (BPH) is a more common form of lower urinary tract symptoms (LUTS). BPH is due to the excessive growth of both stromal and epithelial cells of the prostate. Fifty percent of men over the age of 50 will have this disease, along with the probability that 90% of men at the age of 80 will have an enlarged prostate. The prevalence of vitamin D deficiency in the male urological population may represent a connection between BPH and vitamin D.&lt;/p></description></item><item><title>If parents exposed to pesticides, genes changed. will need more vitamin D to avoid Prostate Cancer</title><link>/posts/if-parents-exposed-to-pesticides-genes-changed-will-need-more-vitamin-d-to-avoid-prostate-cancer.html</link><pubDate>Tue, 09 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/if-parents-exposed-to-pesticides-genes-changed-will-need-more-vitamin-d-to-avoid-prostate-cancer.html</guid><description>&lt;h4 id="pesticide-exposure-and-inherited-variants-in-vitamin-d-pathway-genes-in-relation-to-prostate-cancer">Pesticide exposure and inherited variants in vitamin D pathway genes in relation to prostate cancer&lt;/h4>
&lt;p>Sara Karami1, &lt;a href="mailto:karamis@mail.nih.gov">karamis@mail.nih.gov&lt;/a>; Gabriella Andreotti 2; Stella Koutros 2,&lt;/p>
&lt;p>Kathryn Hughes Barry 3; Lee E. Moore 4; Summer S Han 2,&lt;/p>
&lt;p>Jane A Hoppin 5; Dale P. Sandler 6; Jay H Lubin 3,&lt;/p>
&lt;p>Laurie Burdette 3; Jeffrey Yuenger 7; Meredith Yeager 8,&lt;/p>
&lt;p>Laura Beane Freeman 2; Aaron Blair 3, and Michael C.R. Alavanja3&lt;/p>
&lt;p>1DCEG, National Cancer Institute&lt;/p></description></item><item><title>2X less prostate cancer in A-A with low Calcium is due vitamin D receptor gene</title><link>/posts/2x-less-prostate-cancer-in-a-a-with-low-calcium-is-due-vitamin-d-receptor-gene.html</link><pubDate>Sun, 07 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/2x-less-prostate-cancer-in-a-a-with-low-calcium-is-due-vitamin-d-receptor-gene.html</guid><description>&lt;h4 id="calcium-intake-and-prostate-cancer-among-african-americans-effect-modification-by-vitamin-d-receptor-calcium-absorption-genotype">Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype.&lt;/h4>
&lt;p>J Bone Miner Res. 2012 Jan;27(1):187-94. &lt;a href="https://doi.org/10.1002/jbmr.505.">doi: 10.1002/jbmr.505.&lt;/a>&lt;/p>
&lt;p>Rowland GW, Schwartz GG, John EM, Ingles SA.&lt;/p>
&lt;p>Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.&lt;/p>
&lt;p>High dietary intake of calcium has been classified as a probable cause of prostate cancer, although the mechanism underlying the association between dietary calcium and prostate cancer risk is unclear. The vitamin D receptor (VDR) is a key regulator of calcium absorption. In the small intestine, VDR expression is regulated by the CDX-2 transcription factor, which binds a polymorphic site in the VDR gene promoter. We examined VDR Cdx2 genotype and calcium intake, assessed by a food frequency questionnaire, in 533 African-American prostate cancer cases (256 with advanced stage at diagnosis, 277 with localized stage) and 250 African-American controls who participated in the California Collaborative Prostate Cancer Study. We examined the effects of genotype, calcium intake, and diet-gene interactions by conditional logistic regression. Compared with men in the lowest quartile of calcium intake, men in the highest quartile had an approximately twofold increased risk of localized and advanced prostate cancer (odds ratio &lt;span>[OR]&lt;/span> =  &lt;strong>2.20&lt;/strong> , 95% confidence interval &lt;span>[CI]&lt;/span> = 1.40, 3.46), with a significant dose-response. Poor absorbers of calcium (VDR Cdx2 GG genotype) had a significantly lower risk of advanced prostate cancer (OR = 0.41, 95% CI = 0.19, 0.90). The gene-calcium interaction was statistically significant (p = 0.03). Among men with calcium intake below the median (680 mg/day), carriers of the G allele had an approximately 50% decreased risk compared with men with the AA genotype. These findings suggest a link between prostate cancer risk and high intestinal absorption of calcium.&lt;/p></description></item><item><title>7X increase in stage IV Prostate Cancer survival when vitamin D greater than 32 ng</title><link>/posts/7x-increase-in-stage-iv-prostate-cancer-survival-when-vitamin-d-greater-than-32-ng.html</link><pubDate>Tue, 18 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/7x-increase-in-stage-iv-prostate-cancer-survival-when-vitamin-d-greater-than-32-ng.html</guid><description>&lt;h4 id="the-association-between-pre-treatment-serum-25-hydroxyvitamin-d-and-survival-in-stage-iv-prostate-cancer">The association between pre-treatment serum 25-hydroxyvitamin D and survival in stage IV prostate cancer.&lt;/h4>
&lt;p>Journal of Clinical Oncology, 2013 ASCO Annual Meeting Proceedings (Post-Meeting Edition).&lt;/p>
&lt;p>Vol 31, No 15_suppl (May 20 Supplement), 2013: 5036&lt;/p>
&lt;p>Pankaj G. Vashi, Digant Gupta, Kristen Trukova, Gwendolyn M Lambert and Carolyn Lammersfeld&lt;/p>
&lt;p>Cancer Treatment Centers of America, Zion, IL; Cancer Treatment Centers of America, Schaumburg, IL&lt;/p>
&lt;p>Background: Emerging evidence in the literature suggests a positive association between serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span>, a standard indicator of vitamin D status, and survival in certain types of cancer. We investigated this relationship in newly diagnosed stage IV prostate cancer patients.&lt;/p></description></item><item><title>Hypothesis: Vitamin D restricts blood to prostate cancer cells</title><link>/posts/hypothesis-vitamin-d-restricts-blood-to-prostate-cancer-cells.html</link><pubDate>Sat, 01 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/hypothesis-vitamin-d-restricts-blood-to-prostate-cancer-cells.html</guid><description>&lt;h3 id="role-of-androgen-and-vitamin-d-receptors-in-endothelial-cells-from-benign-and-malignant-human-prostate">Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate&lt;/h3>
&lt;p>AJP - Endo June 1, 2013 vol. 304 no. 11 E1131-E1139&lt;/p>
&lt;p>Alejandro S. Godoy 1,3,4,*,&lt;/p>
&lt;p>Ivy Chung 6,7,*,&lt;/p>
&lt;p>Viviana P. Montecinos 2,3,&lt;/p>
&lt;p>Ralph Buttyan 8,&lt;/p>
&lt;p>Candace S. Johnson 5, and&lt;/p>
&lt;p>Gary J. Smith 4&lt;/p>
&lt;p>1Department of Physiology,&lt;/p>
&lt;p>2Department of Hematology Oncology, and&lt;/p>
&lt;p>3Center for Translational Research in Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile;&lt;/p></description></item><item><title>Overview Prostate Cancer and Vitamin D</title><link>/posts/overview-prostate-cancer-and-vitamin-d.html</link><pubDate>Mon, 27 May 2013 00:00:00 +0000</pubDate><guid>/posts/overview-prostate-cancer-and-vitamin-d.html</guid><description>&lt;p>&lt;strong>Vitamin D both prevents and treats Prostate Cancer somewhat&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#see-also-prostate-problem-bph-reduced-by-herbs-zinc-vitamin-d-etcpostsprostate-problem-bph-reduced-by-herbs-zinc-vitamin-d-etc">See also &lt;a href="/posts/prostate-problem-bph-reduced-by-herbs-zinc-vitamin-d-etc">Prostate problem (BPH) reduced by herbs, Zinc, Vitamin D etc.&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#non-agressive-prostate-cancer-12-x-more-likely-if-low-vitamin-d---jan-2019">Non-agressive Prostate Cancer 1.2 X more likely if low vitamin D - Jan 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dietary-supplements-and-prostate-cancer-a-systematic-review-of-double-blind-placebo-controlled-randomised-clinical-trials---june-2013">Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials. - June 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#using-genetic-proxies-for-lifecourse-sun-exposure-to-assess-the-causal-relationship-of-sun-exposure-with-circulating-vitamin-d-and-prostate-cancer-risk---april-2013">Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk. - April 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#genetic-variation-in-the-vitamin-d-pathway-in-relation-to-risk-of-prostate-cancer--results-from-the-breast-and-prostate-cancer-cohort-consortium---april-2013">Genetic variation in the vitamin d pathway in relation to risk of prostate cancer&amp;ndash;results from the breast and prostate cancer cohort consortium. - April 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-levels-in-subjects-with-prostate-cancer-compared-to-age-matched-controls-2012">Vitamin d levels in subjects with prostate cancer compared to age-matched controls. 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#getting-sun-frequently-reduces-colon-breast-and-prostate-cancer---and-nhl---april-2013">Getting sun frequently reduces colon, breast, and prostate cancer - and NHL - April 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d3-supplementation-low-risk-prostate-cancer-and-health-disparities-dec-2012">Vitamin D(3) supplementation, low-risk prostate cancer, and health disparities. Dec 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#update-on-evidence-that-support-a-role-of-solar-ultraviolet-b-irradiance-in-reducing-cancer-risk---jan-2013">Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk. - Jan 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-sunlight-and-the-epidemiology-of-prostate-cancer---jan-2013">Vitamin d, sunlight, and the epidemiology of prostate cancer. - Jan 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prostate-cancer-vitamin-d-and-genes---march-2013">Prostate cancer, vitamin D and genes - March 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#4000-iu-of-vitamin-d-for-a-yars-reduces-positive-cores---july-2012">4,000 IU of Vitamin D for a yars reduces positive cores - July 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lifestyle-and-dietary-factors-in-the-prevention-of-lethal-prostate-cancer---may-2012">Lifestyle and dietary factors in the prevention of lethal prostate cancer - May 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ultraviolet-index-and-racial-differences-in-prostate-cancer-incidence-and-mortality---june-2-16">Ultraviolet index and racial differences in prostate cancer incidence and mortality. - June 2-16&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#snp-of-vdbp-genes-associated-wih-prostate-cancer-risk-and-grade-but-not-stage---dec-2014">SNP of VDBP genes associated wih Prostate Cancer risk and grade, but not stage - Dec 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#increased-risk-of-prostate-cancer-if-consume-dairy-products-high-grown-factor-in-cows-milk---2023">Increased risk of Prostate Cancer if consume dairy products (high grown factor in cow&amp;rsquo;s milk) - 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prostate-cancer-review-genetics-diagnosis-treatment-options-and-alternative-approaches---sept-2022">Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches - Sept 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#phd-dissertation-on-vitamin-d-to-prevent-prostate-cancer---june-2023">PhD dissertation on Vitamin D to prevent Prostate Cancer - June 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="see-also-prostate-problem-bph-reduced-by-herbs-zinc-vitamin-d-etcpostsprostate-problem-bph-reduced-by-herbs-zinc-vitamin-d-etc">See also &lt;a href="/posts/prostate-problem-bph-reduced-by-herbs-zinc-vitamin-d-etc">Prostate problem (BPH) reduced by herbs, Zinc, Vitamin D etc.&lt;/a>&lt;/h3>
&lt;hr>
&lt;h3 id="non-agressive-prostate-cancer-12-x-more-likely-if-low-vitamin-d---jan-2019">Non-agressive Prostate Cancer 1.2 X more likely if low vitamin D - Jan 2019&lt;/h3>
&lt;p>&lt;strong>A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk&lt;/strong>&lt;/p></description></item><item><title>No indication of association with Prostate Cancer and retinol, vitamin E or active vitamin D</title><link>/posts/no-indication-of-association-with-prostate-cancer-and-retinol-vitamin-e-or-active-vitamin-d.html</link><pubDate>Sat, 25 May 2013 00:00:00 +0000</pubDate><guid>/posts/no-indication-of-association-with-prostate-cancer-and-retinol-vitamin-e-or-active-vitamin-d.html</guid><description>&lt;h2 id="associations-of-circulating-retinol-vitamin-e-and-125-dihydroxyvitamin-d-with-prostate-cancer-diagnosis-stage-and-grade">Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.&lt;/h2>
&lt;p>Cancer Causes Control. 2012 Nov;23(11):1865-73. &lt;a href="https://doi.org/10.1007/s10552-012-0052-5.">doi: 10.1007/s10552-012-0052-5.&lt;/a> Epub 2012 Aug 28.&lt;/p>
&lt;p>Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Lane JA, Martin RM.&lt;/p>
&lt;p>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK. &lt;a href="mailto:becky.gilbert@bristol.ac.uk">becky.gilbert@bristol.ac.uk&lt;/a>&lt;/p>
&lt;p>PURPOSE:&lt;/p>
&lt;p>Some epidemiological studies suggest that vitamin A (retinol), vitamin E, and vitamin D (total 25-hydroxyvitamin D, 25(OH)D; 1,25-dihydroxyvitamin, 1,25(OH)(2)D) are protective against prostate cancer. However, the evidence is not conclusive, &lt;strong>with positive and null associations reported for all three vitamins&lt;/strong> . Limitations of previous studies include small sample size, lack of population controls, and reliance on self-reported dietary intake. Few studies have explored the interactions of circulating 25(OH)D with 1,25(OH)(2)D or retinol, which are biologically plausible interactions.&lt;/p></description></item><item><title>Can take 40,000 IU of vitamin D daily before prostate cancer surgery – RCT</title><link>/posts/can-take-40000-iu-of-vitamin-d-daily-before-prostate-cancer-surgery-rct.html</link><pubDate>Thu, 28 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/can-take-40000-iu-of-vitamin-d-daily-before-prostate-cancer-surgery-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#randomized-clinical-trial-of-vitamin-d3-doses-on-prostatic-vitamin-d-metabolite-levels-and-ki67-labeling-in-prostate-cancer-patients">Randomized Clinical Trial of Vitamin D3 Doses on Prostatic Vitamin D Metabolite Levels and Ki67 Labeling in Prostate Cancer Patients.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-study-of-the-micro-rna-in-the-same-trial">A study of the micro RNA in the same trial&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h2 id="randomized-clinical-trial-of-vitamin-d3-doses-on-prostatic-vitamin-d-metabolite-levels-and-ki67-labeling-in-prostate-cancer-patients">Randomized Clinical Trial of Vitamin D3 Doses on Prostatic Vitamin D Metabolite Levels and Ki67 Labeling in Prostate Cancer Patients.&lt;/h2>
&lt;p>J Clin Endocrinol Metab. 2013 Mar 5.&lt;/p>
&lt;p>Wagner D, Trudel D, Van der Kwast T, Nonn L, Giangreco AA, Li D, Dias A, Cardoza M, Laszlo S, Hersey K, Klotz L, Finelli A, Fleshner N, Vieth R.&lt;/p></description></item><item><title>The sun appears better at reducing incidence of some cancers than vitamin D</title><link>/posts/the-sun-appears-better-at-reducing-incidence-of-some-cancers-than-vitamin-d.html</link><pubDate>Mon, 17 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/the-sun-appears-better-at-reducing-incidence-of-some-cancers-than-vitamin-d.html</guid><description>&lt;h4 id="is-prevention-of-cancer-by-sun-exposure-more-than-just-the-effect-of-vitamin-d--a-systematic-review-of-epidemiological-studies">Is prevention of cancer by sun exposure more than just the effect of vitamin D? -A systematic review of epidemiological studies.&lt;/h4>
&lt;p>Eur J Cancer. 2012 Dec 10. pii: S0959-8049(12)00885-4. &lt;a href="https://doi.org/10.1016/j.ejca.2012.11.001.">doi: 10.1016/j.ejca.2012.11.001.&lt;/a>&lt;/p>
&lt;p>van der Rhee H, Coebergh JW, de Vries E.&lt;/p>
&lt;p>Department of Dermatology, Hagaziekenhuis, P.O. Box 40551, Leyweg 275, 2504 LN Den Haag, Zuid-Holland, The Netherlands. Electronic address: &lt;a href="mailto:hvdrhee@casema.nl">hvdrhee@casema.nl&lt;/a>.&lt;/p>
&lt;p>The number of studies reporting on the association between sunlight exposure, vitamin D and cancer risk is steadily increasing.&lt;/p></description></item><item><title>Vitamin D, Sunlight, and the Epidemiology of Prostate Cancer</title><link>/posts/vitamin-d-sunlight-and-the-epidemiology-of-prostate-cancer.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-sunlight-and-the-epidemiology-of-prostate-cancer.html</guid><description>&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.45-57 (13)&lt;/p>
&lt;p>Author: Gary G. Schwartz&lt;/p>
&lt;p>The hypothesis that vitamin D deficiency increases the risk of clinical prostate cancer has stimulated an extensive body of research. Ecologic studies have shown that mortality rates from prostate cancer are inversely correlated with levels of ultraviolet radiation, the principal source of vitamin D. Human prostate cells express receptors for 1,25-Dihydroxyvitamin D which exerts pleitropic anticancer effects on these cells in vitro and in animal models. Moreover, normal prostate cells synthesize 1,25-Dihydroxyvitamin D from circulating levels of 25-OHD, whose levels are dependent on exposure to ultraviolet light.&lt;/p></description></item><item><title>Cancer - Prostate</title><link>/posts/cancer-prostate.html</link><pubDate>Fri, 16 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/cancer-prostate.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#17-omega-3-and-cancer-studies">17+ Omega-3 and Cancer studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#diet-decreases-cancers-including-prostate-cancer">Diet decreases Cancers, including Prostate Cancer&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="17-omega-3-and-cancer-studies">17+ Omega-3 and Cancer studies&lt;/h4>
&lt;p>&lt;strong>&lt;a href="/posts/pancreatic-cancer-is-increasing-vitamin-d-and-omega-3-should-reduce-the-risk">Pancreatic Cancer is increasing – Vitamin D and Omega-3 should reduce the risk&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="/posts/omega-3-reduces-side-effects-of-cancer-treatments">Omega-3 reduces side effects of Cancer treatments – April 2019&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="/posts/prostate-cancer-psa-reduced-by-60-ng-of-vitamin-d-vitamin-b-complex-omega-3-curcumin-and-diet">Prostate Cancer PSA reduced by 60 ng of Vitamin D, Vitamin B complex, Omega-3, Curcumin and diet – June 2021&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="/posts/omega-3-increases-vitamin-d-in-the-blood-many-studies">Omega 3 increases vitamin D in the blood – many studies&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>PhD Dissertation - Local production of active vitamin D inhibits Prostate Cancer</title><link>/posts/phd-dissertation-local-production-of-active-vitamin-d-inhibits-prostate-cancer.html</link><pubDate>Wed, 07 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/phd-dissertation-local-production-of-active-vitamin-d-inhibits-prostate-cancer.html</guid><description/></item><item><title>600 mg of Calcium and a gene increases probability of Prostate Cancer by 50 pcnt</title><link>/posts/600-mg-of-calcium-and-a-gene-increases-probability-of-prostate-cancer-by-50-pcnt.html</link><pubDate>Tue, 06 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/600-mg-of-calcium-and-a-gene-increases-probability-of-prostate-cancer-by-50-pcnt.html</guid><description>&lt;h3 id="protective-effects-of-low-calcium-intake-and-low-calcium-absorption-vitamin-d-receptor-genotype-in-the-california-collaborative-prostate-cancer-study">Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study&lt;/h3>
&lt;p>Calcium Epidemiology Biomarkers and Prevention, November 5, 2012&lt;/p>
&lt;p>Glovioell W Rowland 1, Gary G. Schwartz 2, Esther M. John 3, and Sue Ann Ingles 4,ingles@usc.edu&lt;/p>
&lt;p>1 Preventive Medicine, University of Southern California&lt;/p>
&lt;p>2 Cancer Biology, Urology, and Epidemiology and Prevention, Wake Forest Baptist Medical Center&lt;/p>
&lt;p>3 Epidemiology, Cancer Prevention Institute of California&lt;/p></description></item><item><title>Prostate Cancer associated with CaSR gene</title><link>/posts/prostate-cancer-associated-with-casr-gene.html</link><pubDate>Tue, 06 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-associated-with-casr-gene.html</guid><description/></item><item><title>Advanced prostate cancer 2X more likely if low vitamin D</title><link>/posts/advanced-prostate-cancer-2x-more-likely-if-low-vitamin-d.html</link><pubDate>Fri, 21 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/advanced-prostate-cancer-2x-more-likely-if-low-vitamin-d.html</guid><description>&lt;h3 id="associations-of-circulating-25-hydroxyvitamin-d-with-prostate-cancer-diagnosis-stage-and-grade">Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.&lt;/h3>
&lt;p>Int J Cancer. 2012 Sep 1;131(5):1187-96. &lt;a href="https://doi.org/10.1002/ijc.27327.">doi: 10.1002/ijc.27327.&lt;/a> Epub 2011 Dec 21.&lt;/p>
&lt;p>Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Lane JA, Martin RM.&lt;/p>
&lt;p>School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom. &lt;a href="mailto:Becky.Gilbert@bristol.ac.uk">Becky.Gilbert@bristol.ac.uk&lt;/a>&lt;/p>
&lt;p>Epidemiological studies suggest that vitamin D protects against prostate cancer, although evidence is limited and inconsistent. We investigated associations of circulating total 25-hydroxyvitamin D (25(OH)D) with prostate specific antigen-detected prostate cancer in a case-control study nested within the prostate testing for cancer and treatment (ProtecT) trial. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) quantifying the association between circulating total 25(OH)D and prostate cancer. In case-only analyses, we used unconditional logistic regression to quantify associations of total 25(OH)D with stage (advanced vs. localized) and Gleason grade (high-grade (?7) vs. low-grade (&amp;lt;7)). Predetermined categories of total 25(OH)D were defined as: high: ?30 ng/mL; adequate: 20-&amp;lt;30 ng/mL; insufficient: 12-&amp;lt;20 ng/mL; deficient: &amp;lt;12 ng/mL. Fractional polynomials were used to investigate the existence of any U-shaped relationship.&lt;/p></description></item><item><title>200 to 500 IU vitamin D does not benefit bones nor prostate cancer</title><link>/posts/200-to-500-iu-vitamin-d-does-not-benefit-bones-nor-prostate-cancer.html</link><pubDate>Thu, 09 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/200-to-500-iu-vitamin-d-does-not-benefit-bones-nor-prostate-cancer.html</guid><description/></item><item><title>Surviving Prostate Cancer - Book</title><link>/posts/surviving-prostate-cancer-book.html</link><pubDate>Fri, 20 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/surviving-prostate-cancer-book.html</guid><description>&lt;h2 id="amazonhttpwwwamazoncompatrick-walshs-surviving-prostate-cancerdp1455504181refsr_1_1sbooksieutf8qid1344653599sr1-1keywordspatrickwalsh27sguidetosurvivingprostatecancer">&lt;a href="http://www.amazon.com/Patrick-Walshs-Surviving-Prostate-Cancer/dp/1455504181/ref=sr_1_1?s=books&amp;amp;ie=UTF8&amp;amp;qid=1344653599&amp;amp;sr=1-1&amp;amp;keywords=+Patrick+Walsh%27s+Guide+to+Surviving+Prostate+Cancer">Amazon&lt;/a>&lt;/h2>
&lt;h3 id="dr-patrick-walshs-guide-to-surviving-prostate-cancer-by-patrick-c-walsh-and-janet-farrar-worthington-jun-19-2012-1129">Dr. Patrick Walsh&amp;rsquo;s Guide to Surviving Prostate Cancer by Patrick C. Walsh and Janet Farrar Worthington (Jun 19, 2012) $11.29&lt;/h3>
&lt;p>3rd edition&lt;/p>
&lt;p>Looking inside the book at Amazon finds Vitamin D mentioned 16 times&lt;/p>
&lt;p>80 5 star reviews on Amazon&lt;/p></description></item><item><title>Low risk Prostate Cancer decreased with 4,000 IU of vitamin D</title><link>/posts/low-risk-prostate-cancer-decreased-with-4000-iu-of-vitamin-d.html</link><pubDate>Sat, 07 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/low-risk-prostate-cancer-decreased-with-4000-iu-of-vitamin-d.html</guid><description>&lt;h4 id="results-in-a-decrease-of-positive-cores-at-repeat-biopsy-in-subjects-with-low-risk-prostate-cancer-under-active-surveillance">Results in a Decrease of Positive Cores at Repeat Biopsy in Subjects with Low-Risk Prostate Cancer under Active Surveillance&lt;/h4>
&lt;p>The Journal of Clinical Endocrinology &amp;amp; Metabolism July 1, 2012 vol. 97 no. 7 2315-2324&lt;/p>
&lt;p>David T. Marshall, Stephen J. Savage, Elizabeth Garrett-Mayer, Thomas E. Keane, Bruce W. Hollis, Ronald L. Horst, Linda H. Ambrose, Mark S. Kindy and Sebastiano Gattoni-Celli&lt;/p>
&lt;p>Departments of Radiation Oncology (D.T.M., L.H.A., S.G.-C.), Urology (S.J.S., T.E.K.), Medicine (Biostatistics) (E.G.-M.), Pediatrics (B.W.H.), and Neurosciences (M.S.K.), Medical University of South Carolina, Charleston, South Carolina 29425; Ralph H. Johnson Veterans Affairs Medical Center (S.J.S., M.S.K., S.G.-C.), Charleston, South Carolina 29401; and Department of Animal Science (R.L.H.), Iowa State University, Ames, Iowa 50011&lt;/p></description></item><item><title>Vitamin D related genes associated with lethal prostate cancer</title><link>/posts/vitamin-d-related-genes-associated-with-lethal-prostate-cancer.html</link><pubDate>Sat, 14 Apr 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-related-genes-associated-with-lethal-prostate-cancer.html</guid><description>&lt;h3 id="vitamin-d-related-genetic-variation-plasma-vitamin-d-and-risk-of-lethal-prostate-cancer">Vitamin D-Related Genetic Variation, Plasma Vitamin D, and Risk of Lethal Prostate Cancer:&lt;/h3>
&lt;p>A Prospective Nested Case-Control Study.&lt;/p>
&lt;p>Shui IM, Mucci LA, Kraft P, Tamimi RM, Lindstrom S, Penney KL, Nimptsch K, Hollis BW, Dupre N, Platz EA, Stampfer MJ, Giovannucci E.&lt;/p>
&lt;p>Affiliations of authors: Department of Epidemiology (IMS, LAM, PK, RMT, SL, KLP, KN, ND, MJS, EG) and Department of Nutrition (KN, MJS, EG), Harvard School of Public Health, Boston, MA; Channing Laboratory, Brigham and Women&amp;rsquo;s Hospital, Harvard Medical School, Boston, MA (LAM, RMT, KLP, MJS, EG); Department of Pediatrics, Medical University of South Carolina, Charleston, SC (BWH); Department of Epidemiology, Johns Hopkins University, Baltimore, MD (EAP); Centre for Public Health Sciences, University of Iceland, Reykjavik, Iceland (LAM).&lt;/p></description></item><item><title>Prostate cancer reduced in high vitamin D two studies</title><link>/posts/prostate-cancer-reduced-in-high-vitamin-d-two-studies.html</link><pubDate>Sun, 01 Apr 2012 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-reduced-in-high-vitamin-d-two-studies.html</guid><description>&lt;h4 id="oral-vitamin-d-supplements-reduced-levels-of-ki67-in-prostate-cancer-cells">Oral Vitamin D Supplements Reduced Levels of Ki67 in Prostate Cancer Cells&lt;/h4>
&lt;p>&lt;a href="http://www.aacr.org/home/public--media/aacr-press-releases.aspx?d=2774">PressRelease&lt;/a> March 31, 2012&lt;/p>
&lt;p>Ki67 is a protein that indicates cancer cell growth.&lt;/p>
&lt;p>Vitamin D increased prostate tissue calcitriol levels, which lowered Ki67.&lt;/p>
&lt;p>CHICAGO — Higher oral doses of plain vitamin D raised levels of calcitriol in prostate tissue. Higher prostate levels of calcitriol, a hormone made from vitamin D, corresponded with lower levels of the proliferation marker Ki67 and increased levels of cancer growth-inhibitory microRNAs in prostate cancer cells, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.&lt;/p></description></item><item><title>Graphs of Vitamin D and Cancer – meta-analysis</title><link>/posts/graphs-of-vitamin-d-and-cancer-meta-analysis.html</link><pubDate>Mon, 26 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/graphs-of-vitamin-d-and-cancer-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-with-or-without-calcium-supplementation-for-prevention-of-cancer-and-fractures-an-updated-meta-analysis-for-the-us-preventive-services-task-force">Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-high-vitamin-d-levels-are-from-those-individuals-with-high-responses-to-only-1000-iu-of-vitamin-d">The high vitamin D levels are from those individuals with high responses to only 1,000 IU of vitamin D&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-with-or-without-calcium-supplementation-for-prevention-of-cancer-and-fractures-an-updated-meta-analysis-for-the-us-preventive-services-task-force">Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force.&lt;/h4>
&lt;p>Ann Intern Med. 2011 Dec 20;155(12):827-38.&lt;/p></description></item><item><title>Prostate cancer in Australia correlates inversely with solar radiation</title><link>/posts/prostate-cancer-in-australia-correlates-inversely-with-solar-radiation.html</link><pubDate>Fri, 18 Nov 2011 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-in-australia-correlates-inversely-with-solar-radiation.html</guid><description>&lt;h1 id="prostate-cancer-incidence-in-australia-correlates-inversely-with-solar-radiation">Prostate cancer incidence in Australia correlates inversely with solar radiation&lt;/h1>
&lt;p>Tim W. Loke1,*, Doruk Sevfi2, Mohamed Khadra2 15 NOV 2011&lt;/p>
&lt;p>BJU International Special Issue: BJU International Australia and New Zealand Supplement&lt;/p>
&lt;p>Volume 108, Issue Supplement s2, pages 66–70, November 2011&lt;/p>
&lt;h2 id="pdf-is-attached-at-the-bottom-of-this-page">PDF is attached at the bottom of this page&lt;/h2>
&lt;p>Increased sun exposure and blood levels of vitamin D have been postulated to be protective against prostate cancer. This is controversial. We investigated the relationship between prostate cancer incidence and solar radiation in non-urban Australia, and found a lower incidence in regions receiving more sunlight.&lt;/p></description></item><item><title>Advanced Prostate Cancer 2X more likely if less than 20ng of vitamin D</title><link>/posts/advanced-prostate-cancer-2x-more-likely-if-less-than-20ng-of-vitamin-d.html</link><pubDate>Sat, 29 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/advanced-prostate-cancer-2x-more-likely-if-less-than-20ng-of-vitamin-d.html</guid><description>&lt;h1 id="associations-of-circulating-25-hydroxyvitamin-d-with-prostate-cancer-diagnosis-stage-and-grade">Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.&lt;/h1>
&lt;p>Int J Cancer. 2011 Oct 27. &lt;a href="https://doi.org/10.1002/ijc.27327.">doi: 10.1002/ijc.27327.&lt;/a>&lt;/p>
&lt;p>Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Athene Lane J, Martin RM.&lt;/p>
&lt;p>School of Social and Community Medicine, University of Bristol. &lt;a href="mailto:Becky.Gilbert@bristol.ac.uk">Becky.Gilbert@bristol.ac.uk&lt;/a>.&lt;/p>
&lt;p>Epidemiological studies suggest that vitamin D protects against prostate cancer, although evidence is limited and inconsistent. We investigated associations of circulating total 25-hydroxyvitamin D (25(OH)D) with PSA-detected prostate cancer in a case-control study nested within the Prostate Testing for Cancer and Treatment (ProtecT) trial. Conditional logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) quantifying the association between circulating total 25(OH)D and prostate cancer. In case-only analyses, we used unconditional logistic regression to quantify associations of total 25(OH)D with stage (advanced vs localized) and Gleason grade (high-grade (?7) vs low-grade (&amp;lt;7)). Pre-determined categories of total 25(OH)D were defined as: high: ?30ng/mL; adequate: 20-&amp;lt;30ng/mL; insufficient: 12-&amp;lt;20ng/mL; deficient: &amp;lt;12ng/mL. Fractional polynomials were used to investigate the existence of any U-shaped relationship. We included 1,447 prostate cancer cases (153 advanced, 469 high-grade) and 1,449 healthy controls.&lt;/p></description></item><item><title>Unsure of association of vitamin D and prostate Cancer - 2011</title><link>/posts/unsure-of-association-of-vitamin-d-and-prostate-cancer-2011.html</link><pubDate>Fri, 14 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/unsure-of-association-of-vitamin-d-and-prostate-cancer-2011.html</guid><description/></item><item><title>Cancers and Vitamin D Council</title><link>/posts/cancers-and-vitamin-d-council.html</link><pubDate>Wed, 07 Sep 2011 00:00:00 +0000</pubDate><guid>/posts/cancers-and-vitamin-d-council.html</guid><description/></item><item><title>More likely to develop Prostate Cancer if have high level of vitamin D in Finland</title><link>/posts/more-likely-to-develop-prostate-cancer-if-have-high-level-of-vitamin-d-in-finland.html</link><pubDate>Wed, 07 Sep 2011 00:00:00 +0000</pubDate><guid>/posts/more-likely-to-develop-prostate-cancer-if-have-high-level-of-vitamin-d-in-finland.html</guid><description>&lt;h1 id="serum-25-hydroxy-vitamin-d-and-prostate-cancer-risk-in-a-large-nested-casecontrol-study">Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case–Control Study&lt;/h1>
&lt;p>Demetrius Albanes, Alison M. Mondul, Kai Yu, Dominick Parisi, Ronald L. Horst, Jarmo Virtamo, Stephanie J. Weinstein&lt;/p>
&lt;p>Authors&amp;rsquo; Affiliations: 1Nutritional Epidemiology Branch and 2 Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda; 3 Information Management Services, Silver Spring, Maryland; 4 Heartland Assays Inc., Ames, Iowa; and 5 Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.&lt;/p></description></item><item><title>Undiagnosed osteoporosis is frequent in prostate cancer</title><link>/posts/undiagnosed-osteoporosis-is-frequent-in-prostate-cancer.html</link><pubDate>Mon, 04 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/undiagnosed-osteoporosis-is-frequent-in-prostate-cancer.html</guid><description>&lt;h4 id="vertebral-fractures-and-the-misclassification-of-osteoporosis-in-men-with-prostate-cancer">Vertebral Fractures and the Misclassification of Osteoporosis in Men With Prostate Cancer&lt;/h4>
&lt;p>Journal of Clinical Densitometry doi:10.1016/j.jocd.2011.05.003&lt;/p>
&lt;p>Sarah Sullivan1, Julie Wagner1, Neil M. Resnick1, Joel Nelson2, Subashan K. Perera1 and Susan L. Greenspan1, corressponding author&lt;/p>
&lt;p>1 School of Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA&lt;/p>
&lt;p>2 School of Urology, University of Pittsburgh, Pittsburgh, PA, USA&lt;/p>
&lt;p>Received 16 March 2011; revised 11 May 2011; accepted 11 May 2011; Available online 1 July 2011.&lt;/p></description></item><item><title>Prostate Cancer – Vitamin D – CYP27B1 – CYP24</title><link>/posts/prostate-cancer-vitamin-d-cyp27b1-cyp24.html</link><pubDate>Wed, 15 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/prostate-cancer-vitamin-d-cyp27b1-cyp24.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-metabolism-and-action-in-the-prostate-implications-for-health-and-disease">Vitamin D metabolism and action in the prostate: Implications for health and disease.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-metabolism-and-action-in-the-prostate-implications-for-health-and-disease">Vitamin D metabolism and action in the prostate: Implications for health and disease.&lt;/h4>
&lt;p>Mol Cell Endocrinol. 2011 Jun 1.&lt;/p>
&lt;p>Swami S, Krishnan AV, Feldman D.&lt;/p>
&lt;p>Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.&lt;/p>
&lt;p>Prostate cancer (PCa) is the second most common cancer in men worldwide. Epidemiological, molecular, and cellular studies have implicated vitamin D deficiency as a risk factor for the development and/or progression of PCa. Studies using cell culture systems and animal models suggest that vitamin D acts to reduce the growth of PCa through regulation of cellular proliferation and differentiation. However, although preclinical studies provide a strong indication for anti-cancer activity, proof of therapeutic benefits in men is still lacking. The anti-proliferative and pro-differentiating properties of vitamin D have been attributed to calcitriol &lt;span>[1,25(OH)(2)D(3)]&lt;/span>, the hormonally active form of vitamin D, acting through the vitamin D receptor (VDR). Metabolism of vitamin D in target tissues is mediated by two key enzymes: 1?-hydroxylase (CYP27B1), which catalyzes the synthesis of calcitriol from 25(OH)D and 24-hydroxylase (CYP24), which catalyzes the initial step in the conversion of calcitriol to less active metabolites. Many factors affect the balance of calcitriol synthesis and catabolism and several maneuvers, like combination therapy of calcitriol with other drugs, have been explored to treat PCa and reduce its risk. The current paper is an overview addressing some of the key factors that influence the biological actions of vitamin D and its metabolites in the treatment and/or prevention of PCa.&lt;/p></description></item><item><title>59 percent more likely to die of Prostate Cancer if very low on vitamin D</title><link>/posts/59-percent-more-likely-to-die-of-prostate-cancer-if-very-low-on-vitamin-d.html</link><pubDate>Wed, 20 Apr 2011 00:00:00 +0000</pubDate><guid>/posts/59-percent-more-likely-to-die-of-prostate-cancer-if-very-low-on-vitamin-d.html</guid><description>&lt;p>Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer.&lt;/p>
&lt;p>PLoS One. 2011 Apr 6;6(4):e18625.&lt;/p>
&lt;p>Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E.&lt;/p>
&lt;p>Channing Laboratory, Department of Medicine, Brigham and Women&amp;rsquo;s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.&lt;/p>
&lt;p>BACKGROUND: Laboratory evidence suggests that vitamin D might influence prostate cancer prognosis.&lt;/p></description></item><item><title>Risk of Prostate Cancer weakly associated with vitamin D - meta-analysis</title><link>/posts/risk-of-prostate-cancer-weakly-associated-with-vitamin-d-meta-analysis.html</link><pubDate>Wed, 30 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/risk-of-prostate-cancer-weakly-associated-with-vitamin-d-meta-analysis.html</guid><description>&lt;h1 id="associations-of-circulating-and-dietary-vitamin-d-with-prostate-cancer-risk-a-systematic-review-and-dose-response-meta-analysis">Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.&lt;/h1>
&lt;p>Cancer Causes Control. 2011 Mar;22(3):319-40. Epub 2011 Jan 4.&lt;/p>
&lt;p>Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.&lt;/p>
&lt;p>Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L, Bekkering GE, Fraser WD, Sterne JA, Metcalfe C.&lt;/p>
&lt;p>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK. &lt;a href="mailto:Becky.Gilbert@Bristol.ac.uk">Becky.Gilbert@Bristol.ac.uk&lt;/a>&lt;/p></description></item><item><title>Vitamin A and risk of prostate cancer</title><link>/posts/vitamin-a-and-risk-of-prostate-cancer.html</link><pubDate>Sun, 13 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-a-and-risk-of-prostate-cancer.html</guid><description/></item><item><title>16 percent less Prostate Cancer sometimes for each 10 ng vitamin D increase - meta-analysis</title><link>/posts/16-percent-less-prostate-cancer-sometimes-for-each-10-ng-vitamin-d-increase-meta-analysis.html</link><pubDate>Thu, 06 Jan 2011 00:00:00 +0000</pubDate><guid>/posts/16-percent-less-prostate-cancer-sometimes-for-each-10-ng-vitamin-d-increase-meta-analysis.html</guid><description>&lt;h4 id="associations-of-circulating-and-dietary-vitamin-d-with-prostate-cancer-risk-a-systematic-review-and-dose-response-meta-analysis">Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.&lt;/h4>
&lt;p>Cancer Causes Control. 2011 Jan 4.&lt;/p>
&lt;p>Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L, Bekkering GE, Fraser WD, Sterne JA, Metcalfe C.&lt;/p>
&lt;p>School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK, &lt;a href="mailto:Becky.Gilbert@Bristol.ac.uk">Becky.Gilbert@Bristol.ac.uk&lt;/a>.&lt;/p>
&lt;p>OBJECTIVE: We systematically reviewed and meta-analyzed literature examining associations of vitamin D (dietary intake, circulating 25-hydroxy-vitamin-D (25(OH)D), and 1,25-dihydroxy-vitamin-D (1,25(OH)(2)D) concentrations) with prostate cancer.&lt;/p></description></item><item><title>8000 IU supplementation to people with various cancers</title><link>/posts/8000-iu-supplementation-to-people-with-various-cancers.html</link><pubDate>Tue, 23 Nov 2010 00:00:00 +0000</pubDate><guid>/posts/8000-iu-supplementation-to-people-with-various-cancers.html</guid><description>&lt;h1 id="impact-of-oral-vitamin-d-supplementation-on-serum-25-hydroxyvitamin-d-levels-in-oncology">Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology&lt;/h1>
&lt;p>Pankaj G Vashi email, Kristen Trukova email, Carolyn A Lammersfeld email, Donald P Braun email and Digant Gupta email&lt;/p>
&lt;p>Nutrition Journal 2010, 9:60doi:10.1186/1475-2891-9-60, 	23 November 2010&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>Serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> is the major circulating form of vitamin D and a standard indicator of vitamin D status. Emerging evidence in the literature suggests a high prevalence of suboptimal vitamin D (as defined by serum 25(OH)D levels of &amp;lt;32 ng/ml) as well as an association between lower serum levels and higher mortality in cancer. We investigated the effect of oral vitamin D supplementation as a means for restoring suboptimal levels to optimal levels in cancer.&lt;/p></description></item><item><title>Epigenetics of prostate cancer and vitamin D</title><link>/posts/epigenetics-of-prostate-cancer-and-vitamin-d.html</link><pubDate>Thu, 08 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/epigenetics-of-prostate-cancer-and-vitamin-d.html</guid><description>&lt;h2 id="epigenetic-regulation-of-vitamin-d-24-hydroxylasecyp24a1-in-human-prostate-cancer">Epigenetic Regulation of Vitamin D 24-Hydroxylase/CYP24A1 in Human Prostate Cancer&lt;/h2>
&lt;p>Cancer Res; 70(14); OF1–10. ©2010 AACR.&lt;/p>
&lt;p>Published OnlineFirst June 29, 2010; &lt;a href="https://doi.org/10.1158/0008-5472.CAN-10-0617">doi: 10.1158/0008-5472.CAN-10-0617&lt;/a>&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Wei Luo1,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Adam R. Karpf1,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Kristin K. Deeb1,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Josephia R. Muindi2,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Carl D. Morrison3,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Candace S. Johnson1, and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Donald L. Trump2&lt;/p>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> Authors' Affiliations: Departments of 1Pharmacology and Therapeutics, 2Medicine, and 3Pathology, Roswell Park Cancer Institute, Buffalo, New York
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;p>Corresponding Author:&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>Donald L. Trump, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 716-845-5772; Fax: 716-845-8261; E-mail: &lt;a href="mailto:donald.trump@roswellpark.org">donald.trump@roswellpark.org&lt;/a>.&lt;/p></description></item><item><title>Vitamin D deficiency after gastrointestinal surgery - 2009</title><link>/posts/vitamin-d-deficiency-after-gastrointestinal-surgery-2009.html</link><pubDate>Tue, 06 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-after-gastrointestinal-surgery-2009.html</guid><description>&lt;h2 id="vitamin--d-deficiency-incidence-and-response-to-oral-supplementation-among--patients-with-various-gastrointestinal-malignancies">Vitamin D deficiency-incidence and response to oral supplementation among patients with various gastrointestinal malignancies.&lt;/h2>
&lt;p>&lt;a href="http://www.asco.org/ASCOv2/Meetings/Abstracts?&amp;amp;vmview=abst_meeting_categories_view&amp;amp;confID=63">2009 Gastrointestinal Cancers Symposium &lt;/a>&lt;/p>
&lt;p>Session Type and Session Title: General Poster Session F&lt;/p>
&lt;p>Abstract No: 329&lt;/p>
&lt;p>Author(s):C. Gilmore, J. James, B. Zubal, D. Thomas, B. R. Tan&lt;/p>
&lt;table>
 &lt;thead>
 &lt;tr>
 &lt;th>&lt;/th>
 &lt;/tr>
 &lt;/thead>
 &lt;tbody>
 &lt;tr>
 &lt;td>&lt;strong>25-OH vitamin D deficiency (%) amongst pts with GI cancers&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>(total n)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>All, (202)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>Male,(100)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>Female, (102)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>Age &amp;lt;65 (131)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>Age &amp;gt;65 (71)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>Colorectal (98)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>Pancreatic (41)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>Other (63)&lt;/strong>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Others: Other biliary (16), HCC (4), neuroendocrine (18), gastric (9), GIST (9), others (7)&lt;/td>
 &lt;/tr>
 &lt;/tbody>
&lt;/table>
&lt;p>&lt;strong>Introduction:&lt;/strong> Vitamin (vit) D deficiency is prevalent amongst patients (pts) with colorectal and pancreatic cancers.&lt;/p></description></item><item><title>Disease Database - nice links for Prostate Cancer</title><link>/posts/disease-database-nice-links-for-prostate-cancer.html</link><pubDate>Thu, 01 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/disease-database-nice-links-for-prostate-cancer.html</guid><description>&lt;table border="1">
&lt;tbody>
&lt;tr>
&lt;th>Site&lt;/th>
&lt;th>Link and description&lt;/th>
&lt;th>Content&lt;/th>
&lt;th>About&lt;/th>
&lt;/tr>
&lt;tr>
&lt;td>ADAM&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nlm.nih.gov/medlineplus/ency/article/000380.htm">Prostate cancer: MedlinePlus Medical Encyclopedia&lt;/a>&lt;/td>
&lt;td>Patient information&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=27297">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>CancerNet (NCI/NIH)&lt;/td>
&lt;td>&lt;a class="external" href="http://www.cancer.gov/cancertopics/understanding-prostate-changes">Understanding Prostate Changes - National Cancer Institute&lt;/a>&lt;/td>
&lt;td>Subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=26124">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>CancerNet (NCI/NIH)&lt;/td>
&lt;td>&lt;a class="external" href="http://www.cancer.gov/cancer_information/doc.aspx?version=1&amp;viewid=f4c08184-f6a9-49d5-8521-7540e59224ac">Prostate Cancer Treatment - National Cancer Institute&lt;/a>&lt;/td>
&lt;td>Subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=9445">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Online Mendelian Inheritance In Man&lt;/td>
&lt;td>&lt;a class="external" href="http://www.ncbi.nlm.nih.gov/omim/176807">PROSTATE CANCER - OMIM Result&lt;/a>&lt;/td>
&lt;td>Subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=2468">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Collaborative Hypertext of Radiology&lt;/td>
&lt;td>&lt;a class="external" href="http://chorus.rad.mcw.edu/doc/00798.html">prostate carcinoma&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=10451">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/458011-overview">Prostate Cancer: Biology, Diagnosis, Pathology, Staging, and Natural History: eMedicine Urology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=17285">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/454114-overview">Prostate Cancer: Metastatic and Advanced Disease: eMedicine Urology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=21444">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/379996-overview">Prostate Carcinoma: eMedicine Radiology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=36386">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab004720.html">Screening for prostate cancer&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=54962">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab005247.html">Chemotherapy for hormone-refractory prostate cancer&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=55327">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab003506.html">Early versus deferred androgen suppression in the treatment of advanced prostatic cancer&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=22604">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab001526.html">Maximal androgen blockade for advanced prostate cancer&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6321">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>NICE&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nice.org.uk/guidance/index.jsp?action=byID&amp;o=11037">Laparoscopic radical prostatectomy&lt;/a>&lt;/td>
&lt;td>Cost effectiveness appraisal&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=42399">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=3494">Prostate Cancer, MedPix™ : 3494 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=396">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=2081">Prostate cancer, MedPix™ : 2081 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=397">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=2456">Prostatic adenocarcinoma, MedPix™ : 2456 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=398">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Madigan Army Medical Center&lt;/td>
&lt;td>&lt;a class="external" href="http://www.mamc.amedd.army.mil/Referral/guidelines/urology_prostatic.htm">Madigan Army Medical Center Prostatic Hypertrophy (Benign) Referral Guidelines&lt;/a>&lt;/td>
&lt;td>Clinical management guideline&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=11102">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>National Guideline Clearinghouse&lt;/td>
&lt;td>&lt;a class="external" href="http://www.guideline.gov/Compare/comparison.aspx?file=PROSCREEN12.inc">NGC - Compare - Comparison&lt;/a>&lt;/td>
&lt;td>Clinical management guideline&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=74076">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>NICE&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nice.org.uk/Guidance/CG58">Prostate cancer&lt;/a>&lt;/td>
&lt;td>Clinical management guideline&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=68263">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;/tbody>
&lt;/table>
&lt;hr />
&lt;h3>Search elsewhere for Prostate cancer&lt;/h3>
&lt;p>&lt;noscript>&lt;b class='look'>JavaScript must be enabled for some links on this page.&lt;/b>&lt;/noscript>&lt;/p></description></item><item><title>Meta-analysis found vitamin D association with colon but not prostate nor breast cancer</title><link>/posts/meta-analysis-found-vitamin-d-association-with-colon-but-not-prostate-nor-breast-cancer.html</link><pubDate>Tue, 18 May 2010 00:00:00 +0000</pubDate><guid>/posts/meta-analysis-found-vitamin-d-association-with-colon-but-not-prostate-nor-breast-cancer.html</guid><description>&lt;h1 id="meta-analysis-of-observational-studies-of-serum-25-hydroxyvitamin-d-levels-and-colorectal-breast-and-prostate-cancer-and-colorectal-adenoma">Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.&lt;/h1>
&lt;p>Int J Cancer. 2010 May 6.&lt;/p>
&lt;p>Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P.&lt;/p>
&lt;p>European Institute of Oncology, Milano, Italy.&lt;/p>
&lt;p>Epidemiological studies have suggested a reduced risk of several cancers associated with high vitamin D status. We performed a systematic review with meta-analyses of observational studies of serum 25-hydroxyvitamin D level and colorectal, breast and prostate cancer, and colonic adenoma. The literature to December 2009 was searched without language restriction. The meta-regression analysis was done in order to compute dose-response effects. Because in case-control studies, serum 25-hydroxyvitamin D level is measured after the diagnosis of cancer, separate analyses for case-control and prospective studies were done. We identified 35 independent studies. The seven studies on colorectal adenomas were heterogeneous in terms of endpoint and control for major confounding factors, and we did not perform a meta-analysis of these data.&lt;/p></description></item><item><title>Possible reduction in nocturia, nighttime urination, or BPH after taking vitamin D</title><link>/posts/possible-reduction-in-nocturia-nighttime-urination-or-bph-after-taking-vitamin-d.html</link><pubDate>Fri, 07 May 2010 00:00:00 +0000</pubDate><guid>/posts/possible-reduction-in-nocturia-nighttime-urination-or-bph-after-taking-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#bph-and-vitamin-d---5800-studies-in-google-scholar-as-of-april-2022">BPH and Vitamin D - 5,800 studies in Google Scholar as of April 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nocturia-and-vitamin-d---3700-studies-in-google-scholar-as-of-april-2022">Nocturia and Vitamin D - 3,700 studies in Google Scholar as of April 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="bph-and-vitamin-d---5800-studies-in-google-scholar-as-of-april-2022">BPH and Vitamin D - 5,800 studies in Google Scholar as of April 2022&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://scholar.google.com/scholar?hl=en&amp;amp;as_sdt=0%2C48&amp;amp;q=bph+%22vitamin+d%22&amp;amp;btnG=">Google Scholar&lt;/a>&lt;/strong> examples&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Vitamin D and benign prostatic hyperplasia-a review - 2013&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia - 2012&lt;/p></description></item><item><title>Daily 377 IU of Vit D did not treat prostate cancer – Cancer Journal</title><link>/posts/daily-377-iu-of-vit-d-did-not-treat-prostate-cancer-cancer-journal.html</link><pubDate>Thu, 06 May 2010 00:00:00 +0000</pubDate><guid>/posts/daily-377-iu-of-vit-d-did-not-treat-prostate-cancer-cancer-journal.html</guid><description>&lt;h1 id="vitamin-d-considerations-in-the-continued-development-as-an-agent-for-cancer-prevention-and-therapy">Vitamin D: Considerations in the Continued Development as an Agent for Cancer Prevention and Therapy&lt;/h1>
&lt;p>The Cancer Journal: January/February 2010 - Volume 16 - Issue 1 - pp 1-9&lt;/p>
&lt;p>&lt;a href="https://doi.org/10.1097/PPO.0b013e3181c51ee6">doi: 10.1097/PPO.0b013e3181c51ee6&lt;/a>&lt;/p>
&lt;p>Trump, Donald L. MD; Deeb, Kristin K. PhD; Johnson, Candace S. PhD&lt;/p>
&lt;p>Considerable preclinical and epidemiologic data suggest that vitamin D may play a role in the pathogenesis, progression, and therapy for cancer. Numerous epidemiologic studies support the hypothesis that individuals with lower serum vitamin D levels have a higher risk of a number of cancers. Measures of vitamin D level in such studies include both surrogate estimates of vitamin D level (residence in more northern latitudes, history of activity, and sun exposure) as well as measured serum 25(OH) cholecalciferol levels. Perhaps, the most robust of these epidemiologic studies is that of Giovannucci et al, who developed and validated an estimate of serum 25(OH) cholecalciferol level and reported that among &amp;gt;40,000 individuals in the Health Professionals Study, an increase in 25(OH) cholecalciferol level of 62.5 ng/mL was associated with a reduction in the risk of head/neck, esophagus, pancreas cancers, and acute leukemia by &amp;gt;50%.&lt;/p></description></item></channel></rss>